data_5uhu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5uhu _Structure_validation_residue.Date_analyzed 2017-08-18 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 115.085 -2.388 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.47 166.65 18.94 Favored 'Trans proline' 0 C--O 1.264 1.816 0 CA-C-N 125.179 2.885 . . . . 0.0 111.736 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 35' ' ' VAL . 91.1 mtt-85 -110.71 149.73 30.06 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.06 115.62 20.6 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 127.719 2.408 . . . . 0.0 109.625 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.516 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 10.3 t80 -101.94 150.49 37.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 127.205 2.202 . . . . 0.0 108.103 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HA ' ' CG ' ' A' ' 9' ' ' TYR . 30.0 Cg_exo -72.69 160.21 95.42 Favored 'Cis proline' 0 C--N 1.399 3.228 0 CA-C-O 125.783 2.326 . . . . 0.0 114.327 -1.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -95.85 -33.43 12.23 Favored 'General case' 1 C--O 1.309 4.232 0 O-C-N 118.428 -2.67 . . . . 0.0 110.029 174.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -65.36 171.55 3.83 Favored 'General case' 0 N--CA 1.512 2.672 1 O-C-N 116.248 -4.032 . . . . 0.0 111.336 151.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -157.99 144.77 17.8 Favored 'General case' 1 C--O 1.312 4.346 0 O-C-N 119.774 -1.829 . . . . 0.0 111.284 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -50.18 -33.89 10.31 Favored 'Isoleucine or valine' 0 C--N 1.377 1.779 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.6 73.86 9.34 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 117.66 -3.15 . . . . 0.0 114.163 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.27 177.22 42.47 Favored Glycine 0 N--CA 1.487 2.083 1 CA-C-O 113.299 -4.056 . . . . 0.0 114.692 167.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.311 13.1 mt -128.6 -37.73 1.76 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 175.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -92.65 -178.75 4.96 Favored 'General case' 0 C--O 1.268 2.029 0 C-N-CA 114.992 -2.683 . . . . 0.0 109.093 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -63.68 121.3 13.62 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 118.359 -2.713 . . . . 0.0 109.184 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . 0.277 . . -58.8 131.52 51.19 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -173.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.94 -31.63 58.66 Favored Glycine 0 CA--C 1.558 2.749 0 O-C-N 119.317 -2.115 . . . . 0.0 115.985 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -72.53 -20.59 61.32 Favored 'General case' 0 C--O 1.262 1.762 0 CA-C-O 116.158 -1.877 . . . . 0.0 110.478 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -53.43 7.84 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.92 -12.2 67.65 Favored Glycine 0 CA--C 1.564 3.132 0 O-C-N 118.991 -2.318 . . . . 0.0 113.519 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -92.34 -26.35 18.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 120.251 -1.735 . . . . 0.0 110.067 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.79 -30.05 29.14 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-N 120.899 1.682 . . . . 0.0 110.722 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -53.96 -24.22 15.8 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 116.311 -1.804 . . . . 0.0 115.247 160.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -98.02 -35.11 10.54 Favored 'General case' 0 C--N 1.393 2.49 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -104.97 -7.57 19.18 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.2 75.88 10.46 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-O 128.428 3.966 . . . . 0.0 116.515 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -70.37 -12.37 31.63 Favored 'Trans proline' 0 C--O 1.189 -1.962 0 O-C-N 113.813 -3.835 . . . . 0.0 115.632 -158.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.95 118.11 27.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.277 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 154.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 m -100.4 158.42 15.91 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-O 113.774 -3.012 . . . . 0.0 117.593 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -88.08 136.44 32.97 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 127.284 2.865 . . . . 0.0 106.042 156.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ARG . 6.8 m -129.61 147.18 33.3 Favored 'Isoleucine or valine' 0 C--O 1.254 1.313 0 O-C-N 128.042 3.339 . . . . 0.0 110.166 -177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -111.28 112.79 54.58 Favored Pre-proline 0 C--O 1.267 1.982 0 C-N-CA 129.271 3.028 . . . . 0.0 106.442 155.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -73.68 -171.78 0.93 Allowed 'Trans proline' 0 N--CA 1.418 -2.926 0 CA-C-O 128.649 3.521 . . . . 0.0 109.12 159.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -87.52 -23.16 1.44 Allowed 'Trans proline' 1 CA--C 1.625 5.026 0 O-C-N 114.254 -3.603 . . . . 0.0 109.985 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.1 133.66 50.38 Favored 'General case' 0 CA--C 1.484 -1.563 0 O-C-N 117.393 -3.317 . . . . 0.0 114.767 172.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA3' ' HA ' ' A' ' 72' ' ' PRO . . . 107.89 176.53 22.28 Favored Glycine 0 N--CA 1.493 2.488 1 O-C-N 114.382 -5.199 . . . . 0.0 112.415 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.65 176.32 5.62 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 127.421 3.486 . . . . 0.0 111.928 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.02 152.9 36.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 118.039 -2.913 . . . . 0.0 109.871 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.27 165.57 27.11 Favored 'General case' 0 C--O 1.178 -2.699 0 CA-C-O 124.838 2.256 . . . . 0.0 114.284 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -84.18 149.89 25.86 Favored 'General case' 0 CA--C 1.558 1.271 0 O-C-N 120.528 -1.357 . . . . 0.0 108.627 162.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.13 112.21 13.74 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.248 -0.907 . . . . 0.0 111.983 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.08 132.13 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.049 0 C-N-CA 128.282 2.633 . . . . 0.0 110.622 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.5 p -121.17 -27.39 4.91 Favored 'General case' 0 CA--C 1.561 1.367 1 C-N-CA 132.324 4.249 . . . . 0.0 116.851 -160.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 mmm-85 -100.29 147.41 25.8 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.4 -167.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -49.1 -62.64 1.43 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 124.291 1.996 . . . . 0.0 108.165 -169.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.275 70.0 mm-40 -76.01 -9.81 58.92 Favored 'General case' 0 C--O 1.192 -1.966 0 CA-C-O 123.771 1.748 . . . . 0.0 114.269 -170.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.58 -32.77 25.6 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 117.719 -3.113 . . . . 0.0 109.838 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.42 -36.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 O-C-N 118.359 -2.713 . . . . 0.0 109.648 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -57.59 -29.42 64.46 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 116.644 -1.646 . . . . 0.0 112.548 162.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 -50.29 22.47 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 168.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.08 -25.05 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.186 0 CA-C-N 119.835 1.198 . . . . 0.0 110.232 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -98.39 35.42 1.79 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-O 124.55 2.119 . . . . 0.0 110.023 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.92 23.69 0.47 Allowed Glycine 0 C--N 1.292 -1.891 0 O-C-N 117.478 -3.264 . . . . 0.0 119.071 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -138.44 135.77 35.55 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 120.174 1.987 . . . . 0.0 108.456 168.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.96 -14.63 53.55 Favored Glycine 0 C--O 1.188 -2.779 0 CA-C-O 116.528 -2.262 . . . . 0.0 114.702 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -84.53 -3.52 58.46 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -99.44 121.71 41.51 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 119.575 1.08 . . . . 0.0 111.994 160.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.94 167.15 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 124.755 1.222 . . . . 0.0 113.475 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -80.04 -21.38 43.54 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 115.538 -2.172 . . . . 0.0 113.407 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.53 -45.21 93.36 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-N 122.529 2.422 . . . . 0.0 117.148 -150.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.59 -27.65 8.0 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 124.037 3.158 . . . . 0.0 115.868 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.0 p -50.46 -20.4 1.12 Allowed 'General case' 0 C--O 1.298 3.628 0 CA-C-N 124.04 3.109 . . . . 0.0 113.469 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -10.22 59.25 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 119.908 -1.745 . . . . 0.0 112.871 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.5 p -138.96 18.56 2.64 Favored 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.827 0.823 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.251 22.1 mtp180 -135.92 151.92 50.46 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 118.726 -2.484 . . . . 0.0 108.784 167.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -72.08 106.4 4.31 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.743 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.05 138.67 30.79 Favored Pre-proline 0 CA--C 1.491 -1.303 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -158.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HA ' ' HA3' ' A' ' 40' ' ' GLY . 1.7 Cg_endo -64.87 104.13 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-O 116.917 -1.368 . . . . 0.0 114.829 -172.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -145.79 168.71 20.1 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 125.958 1.703 . . . . 0.0 112.412 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 27.5 p -88.67 -8.37 54.7 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 119.919 3.303 . . . . 0.0 119.919 176.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -126.34 156.49 72.52 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 117.217 -3.427 . . . . 0.0 116.394 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.74 -49.35 4.27 Favored 'Trans proline' 1 N--CA 1.397 -4.159 1 C-N-CA 127.88 5.72 . . . . 0.0 111.404 -166.318 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -72.71 152.77 41.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.5 mtt -76.88 155.58 32.77 Favored 'General case' 0 CA--C 1.56 1.353 0 O-C-N 119.879 -1.763 . . . . 0.0 108.897 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.2 t -67.09 94.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 124.827 2.251 . . . . 0.0 108.737 166.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.312 43.4 mmtt -105.94 -19.62 13.68 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 117.482 -3.261 . . . . 0.0 116.755 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.76 143.32 14.95 Favored Glycine 0 N--CA 1.506 3.326 0 CA-C-N 125.291 3.678 . . . . 0.0 116.344 -171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.61 159.97 22.11 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 127.327 3.737 . . . . 0.0 109.979 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -42.38 -28.43 0.21 Allowed 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 119.872 3.286 . . . . 0.0 119.872 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 tp -78.04 -0.69 28.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.49 -1.381 . . . . 0.0 113.53 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -88.92 19.59 4.03 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 123.596 1.665 . . . . 0.0 114.04 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.5 mtt -149.34 159.3 44.4 Favored 'General case' 0 N--CA 1.525 3.315 0 O-C-N 117.304 -3.372 . . . . 0.0 111.358 -158.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -142.91 151.12 55.52 Favored Pre-proline 0 C--N 1.363 1.184 0 O-C-N 117.71 -3.119 . . . . 0.0 112.729 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -64.31 144.98 87.72 Favored 'Trans proline' 0 C--O 1.274 2.313 0 C-N-CA 124.626 3.551 . . . . 0.0 116.337 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.15 -14.16 25.92 Favored 'Cis proline' 1 N--CA 1.547 4.625 0 O-C-N 125.271 2.195 . . . . 0.0 115.223 5.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.81 -26.32 68.29 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 118.889 -2.382 . . . . 0.0 116.632 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -77.25 -37.71 52.57 Favored 'General case' 0 C--O 1.262 1.745 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -62.27 -46.68 87.71 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . 0.412 0.1 OUTLIER -58.5 -33.13 69.46 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 119.871 -1.768 . . . . 0.0 109.567 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -51.0 10.13 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 117.013 -1.875 . . . . 0.0 113.771 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.15 -45.98 91.22 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 114.401 -2.714 . . . . 0.0 115.877 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -46.46 -36.25 6.42 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 125.349 3.704 . . . . 0.0 116.32 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . 0.348 1.3 tt -74.26 -60.1 2.42 Favored 'General case' 0 CA--C 1.616 3.487 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.755 175.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.27 22.9 m -65.33 -28.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 114.077 -2.868 . . . . 0.0 109.045 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.0 m -68.39 -20.98 25.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 121.42 1.918 . . . . 0.0 115.737 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -76.75 -22.54 53.65 Favored 'General case' 0 N--CA 1.527 3.383 0 CA-C-O 115.643 -2.123 . . . . 0.0 111.593 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.3 -34.9 3.94 Favored 'General case' 0 C--O 1.272 2.239 0 CA-C-N 120.245 1.384 . . . . 0.0 111.368 -170.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -73.74 48.03 0.27 Allowed 'General case' 0 CA--C 1.564 1.491 0 O-C-N 118.461 -2.649 . . . . 0.0 110.49 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -69.69 157.18 37.76 Favored 'General case' 0 CA--C 1.569 1.7 1 N-CA-C 123.472 4.619 . . . . 0.0 123.472 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.68 -29.34 61.19 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.61 2.444 . . . . 0.0 113.401 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.322 16.7 ttt-85 -61.38 -51.26 69.51 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 167.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -55.52 -36.5 66.8 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.831 1.252 . . . . 0.0 112.989 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . 0.357 . . -59.18 -54.34 48.01 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.25 4.5 tp10 -49.06 -46.59 44.66 Favored 'General case' 0 CA--C 1.6 2.886 0 CA-C-O 121.821 0.82 . . . . 0.0 112.802 171.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.5 m -76.75 5.5 7.58 Favored 'General case' 0 C--O 1.278 2.604 0 O-C-N 121.372 -0.83 . . . . 0.0 112.865 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.48 -26.58 14.4 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 124.086 0.954 . . . . 0.0 113.09 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -48.94 -42.0 57.14 Favored Pre-proline 1 CA--C 1.665 5.397 0 CA-C-O 112.937 -3.411 . . . . 0.0 111.427 -174.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -58.56 -49.91 10.75 Favored 'Trans proline' 1 CA--C 1.604 4.002 0 O-C-N 124.814 1.955 . . . . 0.0 109.532 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -68.78 -33.38 73.79 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -33.08 72.46 Favored 'General case' 0 C--O 1.176 -2.804 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.585 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.409 HH11 ' CD ' ' A' ' 361' ' ' GLU . 29.7 mtt180 -73.86 -36.69 64.87 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 117.673 -3.142 . . . . 0.0 107.814 175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.36 -25.12 60.46 Favored 'General case' 0 C--O 1.254 1.319 0 O-C-N 125.636 1.835 . . . . 0.0 113.519 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.276 24.0 mt -66.51 -63.48 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 160.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.88 -44.51 39.99 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.56 -33.73 76.33 Favored 'General case' 0 C--O 1.254 1.314 0 O-C-N 118.136 -2.852 . . . . 0.0 111.7 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -72.74 -41.98 64.58 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 117.15 -3.469 . . . . 0.0 108.794 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.5 -36.15 79.68 Favored 'General case' 0 C--O 1.26 1.612 0 O-C-N 116.665 -3.772 . . . . 0.0 108.431 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.9 t -79.93 -30.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 117.964 -2.96 . . . . 0.0 113.969 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -61.76 -48.54 80.23 Favored 'General case' 0 CA--C 1.615 3.456 0 C-N-CA 126.029 1.732 . . . . 0.0 109.304 168.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.75 -31.69 68.59 Favored 'General case' 0 N--CA 1.537 3.885 0 O-C-N 118.373 -2.704 . . . . 0.0 110.457 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.9 ttp -61.19 -53.66 54.15 Favored 'General case' 0 C--O 1.259 1.604 0 O-C-N 116.391 -3.943 . . . . 0.0 110.617 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.77 -49.16 71.56 Favored 'General case' 0 C--O 1.256 1.442 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.104 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . 0.343 . . -64.65 -18.94 65.41 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 129.526 3.131 . . . . 0.0 117.975 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 m -84.46 -21.92 30.5 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 114.828 -2.51 . . . . 0.0 111.026 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.53 179.55 49.56 Favored Glycine 1 N--CA 1.544 5.853 0 CA-C-N 122.576 2.444 . . . . 0.0 112.155 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.28 157.59 53.06 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 127.379 2.458 . . . . 0.0 114.08 -169.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -67.27 159.1 81.9 Favored 'Cis proline' 0 C--O 1.287 2.963 0 O-C-N 123.719 1.378 . . . . 0.0 110.23 -7.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.77 161.22 21.83 Favored 'General case' 0 CA--C 1.586 2.335 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.091 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -93.11 114.3 26.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.399 1.0 . . . . 0.0 112.402 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . 0.284 11.8 tp -72.73 -14.36 61.54 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 114.218 -1.356 . . . . 0.0 113.835 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.65 -44.73 20.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 1 O-C-N 115.373 -4.579 . . . . 0.0 110.239 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.9 -33.29 62.02 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.494 -1.682 . . . . 0.0 107.457 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.0 mtt -100.66 -6.54 25.01 Favored 'General case' 0 C--O 1.201 -1.476 0 O-C-N 119.07 -2.269 . . . . 0.0 110.904 -171.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -135.08 -69.3 0.51 Allowed 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.22 -29.0 67.2 Favored 'General case' 0 CA--C 1.594 2.638 1 O-C-N 115.834 -4.291 . . . . 0.0 114.407 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.48 -18.06 57.46 Favored 'General case' 1 N--CA 1.556 4.837 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . 0.258 50.1 mm-40 -114.13 -15.4 12.24 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 114.536 -2.649 . . . . 0.0 113.905 -164.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 22.7 tp -80.48 -50.91 1.06 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 111.746 -3.978 . . . . 0.0 108.716 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -57.9 -52.75 5.37 Favored 'Trans proline' 0 N--CA 1.518 2.931 0 CA-C-N 125.137 2.87 . . . . 0.0 110.892 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.4 -33.08 61.12 Favored 'Isoleucine or valine' 0 C--O 1.27 2.164 0 CA-C-O 114.649 -2.595 . . . . 0.0 107.515 -160.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.291 64.6 mtt180 -71.91 -49.64 36.0 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 126.804 2.565 . . . . 0.0 114.768 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.72 -48.49 77.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 120.856 1.662 . . . . 0.0 109.63 171.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.69 -32.54 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 128.294 2.638 . . . . 0.0 107.751 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.7 m -78.1 -23.05 48.07 Favored 'General case' 0 C--O 1.187 -2.214 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -67.95 -53.57 25.26 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 110.347 -3.115 . . . . 0.0 110.391 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.5 tp -48.72 -26.03 2.11 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.96 -6.03 36.5 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 121.064 -1.023 . . . . 0.0 113.57 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.85 62.06 Favored Glycine 0 C--O 1.272 2.488 0 C-N-CA 127.835 2.636 . . . . 0.0 111.065 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.7 t -82.78 136.52 44.66 Favored Pre-proline 0 C--O 1.2 -1.525 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.859 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . 0.392 27.4 Cg_exo -51.41 139.09 46.47 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 C-N-CA 122.568 2.179 . . . . 0.0 116.693 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 84.7 p -57.11 -36.65 70.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.54 65.04 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -97.59 -6.13 34.05 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.022 -1.673 . . . . 0.0 114.524 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -60.92 -26.75 67.7 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 116.516 -2.074 . . . . 0.0 112.566 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -57.33 -53.29 59.85 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 117.947 -2.971 . . . . 0.0 111.822 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -56.24 -55.39 33.89 Favored 'General case' 0 C--N 1.385 2.109 0 C-N-CA 121.228 -0.189 . . . . 0.0 110.527 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.411 ' CD1' HD22 ' A' ' 232' ' ' LEU . 18.1 m-85 -53.36 -34.15 56.46 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 118.807 2.891 . . . . 0.0 118.807 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 91.4 m -56.84 -57.22 13.43 Favored 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.219 1.009 . . . . 0.0 108.541 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 43.5 ttm105 -63.8 -28.38 69.82 Favored 'General case' 0 C--N 1.393 2.482 0 C-N-CA 128.591 2.756 . . . . 0.0 114.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TRP . . . . . . . . . . . . 0.301 46.3 m0 -76.02 -63.88 1.22 Allowed 'General case' 0 N--CA 1.433 -1.325 0 O-C-N 118.555 -2.591 . . . . 0.0 114.325 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.7 m -57.28 -38.45 73.93 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.917 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.4 61.53 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 129.521 3.438 . . . . 0.0 113.706 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.25 38.38 Favored 'General case' 0 C--N 1.282 -2.348 1 O-C-N 115.191 -4.711 . . . . 0.0 110.994 175.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -84.28 -14.6 49.35 Favored 'General case' 0 CA--C 1.603 3.015 0 CA-C-N 122.415 2.371 . . . . 0.0 115.159 162.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.21 143.13 35.65 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 119.898 -1.751 . . . . 0.0 110.637 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 71.9 m -79.34 -27.76 42.05 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.239 166.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.68 5.91 12.1 Favored 'General case' 0 C--O 1.264 1.832 0 CA-C-N 121.981 2.173 . . . . 0.0 114.71 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -140.24 163.69 32.09 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 117.598 -3.189 . . . . 0.0 113.878 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.438 ' CD ' HH22 ' A' ' 380' ' ' ARG . 40.5 mt-10 -126.84 83.98 2.22 Favored 'General case' 0 CA--C 1.609 3.222 0 CA-C-O 125.389 2.519 . . . . 0.0 109.875 -171.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.08 158.75 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 O-C-N 117.592 -3.192 . . . . 0.0 111.768 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 p -97.77 175.64 6.1 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 125.701 2.667 . . . . 0.0 108.825 -165.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.372 1.562 0 O-C-N 119.75 -1.844 . . . . 0.0 109.45 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.06 -22.95 65.07 Favored 'General case' 0 CA--C 1.461 -2.451 0 O-C-N 116.994 -3.566 . . . . 0.0 111.875 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 9.2 mp0 -85.97 -31.3 22.15 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-O 114.02 -2.895 . . . . 0.0 110.852 169.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 61.1 mtm -60.43 -36.31 77.89 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 125.985 3.993 . . . . 0.0 110.736 170.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.49 -39.76 95.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.505 3.122 . . . . 0.0 109.49 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -65.61 -48.53 71.94 Favored 'General case' 0 C--N 1.38 1.913 0 O-C-N 118.344 -2.723 . . . . 0.0 113.763 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.21 86.88 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.05 -27.52 60.96 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.03 -46.85 14.4 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.275 2.23 . . . . 0.0 114.197 175.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -108.93 -15.45 14.37 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 118.861 2.912 . . . . 0.0 118.861 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . 0.259 . . -92.75 -35.13 13.61 Favored 'General case' 0 CA--C 1.486 -1.515 1 O-C-N 115.048 -4.783 . . . . 0.0 111.034 -166.301 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.11 -30.1 62.16 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.92 -38.55 64.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 124.445 1.09 . . . . 0.0 112.75 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.64 -33.8 76.73 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 12.0 tpp -75.62 -31.75 60.0 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.075 -1.85 . . . . 0.0 113.102 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.42 77.65 Favored Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -44.88 -41.48 7.17 Favored 'General case' 0 CA--C 1.619 3.615 0 O-C-N 119.053 -2.439 . . . . 0.0 110.538 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 19.5 tp -84.25 -37.17 22.09 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 117.763 -3.086 . . . . 0.0 113.705 -178.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.14 -46.68 84.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 125.048 1.339 . . . . 0.0 108.476 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 120.741 1.61 . . . . 0.0 109.494 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -51.41 -44.8 62.36 Favored 'General case' 0 C--N 1.395 2.553 0 CA-C-O 125.761 2.696 . . . . 0.0 112.887 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -71.62 -27.63 63.23 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 118.809 -2.432 . . . . 0.0 112.083 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -72.36 -49.99 30.0 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 122.573 1.178 . . . . 0.0 109.354 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -48.55 -53.21 19.11 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.27 -2.241 . . . . 0.0 111.906 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -146.45 115.01 4.5 Favored Pre-proline 0 CA--C 1.595 2.69 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.38 144.72 29.37 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 O-C-N 117.113 -2.098 . . . . 0.0 113.179 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -146.48 179.48 7.51 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 127.871 2.468 . . . . 0.0 107.574 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.36 -4.11 59.11 Favored 'General case' 0 C--N 1.377 1.793 0 O-C-N 117.302 -3.374 . . . . 0.0 112.45 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.07 166.53 5.8 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 119.293 -2.129 . . . . 0.0 114.788 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.67 -43.95 79.0 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 118.685 0.675 . . . . 0.0 112.436 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . . . . . . . . . 2.5 t -56.69 -36.01 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.2 m -62.37 -46.25 89.48 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 126.855 2.062 . . . . 0.0 115.727 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.52 -29.81 70.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.1 1.5 . . . . 0.0 109.927 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.72 -30.54 23.04 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.157 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.458 4.9 m -69.42 -12.03 15.55 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 119.849 3.277 . . . . 0.0 119.849 158.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -106.78 -36.44 6.68 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-N 119.538 1.063 . . . . 0.0 109.934 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.2 149.89 42.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -134.79 154.22 51.7 Favored 'General case' 0 C--O 1.247 0.969 1 CA-C-O 110.409 -4.615 . . . . 0.0 111.234 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -93.09 107.07 18.94 Favored 'General case' 0 C--N 1.248 -3.82 1 O-C-N 129.978 4.549 . . . . 0.0 110.019 162.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 60.74 -92.25 0.03 OUTLIER 'General case' 0 C--O 1.168 -3.222 0 O-C-N 126.891 2.62 . . . . 0.0 109.752 -164.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -129.26 5.71 5.29 Favored 'General case' 0 C--O 1.177 -2.742 0 CA-C-N 120.45 1.477 . . . . 0.0 109.937 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.38 140.95 55.86 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 121.041 1.746 . . . . 0.0 114.868 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.6 m -113.72 131.37 56.2 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 123.927 1.823 . . . . 0.0 111.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LEU . . . . . . . . . . . . . 13.3 tp -70.46 106.1 3.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.866 -2.425 . . . . 0.0 110.646 170.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 37.0 m -73.4 169.34 17.36 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 117.375 -3.328 . . . . 0.0 113.704 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -43.31 52.41 Favored 'General case' 0 C--O 1.19 -2.065 0 O-C-N 126.032 2.082 . . . . 0.0 114.917 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.2 -39.07 82.54 Favored 'General case' 0 C--O 1.272 2.277 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.636 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.78 -29.7 69.72 Favored 'General case' 0 C--N 1.378 1.828 0 C-N-CA 126.911 2.084 . . . . 0.0 116.007 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 1.6 tt -93.69 -41.53 9.65 Favored 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 125.784 1.634 . . . . 0.0 109.88 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 47.6 tp -51.93 -51.95 53.47 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.484 -0.76 . . . . 0.0 112.436 160.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.8 -58.6 6.66 Favored 'General case' 0 C--O 1.267 1.976 0 O-C-N 117.929 -2.982 . . . . 0.0 113.705 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.86 -51.55 39.34 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.072 0.939 . . . . 0.0 111.514 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.41 93.48 Favored 'General case' 0 CA--C 1.587 2.376 0 CA-C-N 111.993 -2.367 . . . . 0.0 115.854 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 4.7 tp -62.46 -49.77 82.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.703 0 O-C-N 119.836 -1.79 . . . . 0.0 108.98 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -51.09 -36.37 35.1 Favored Glycine 0 C--N 1.373 2.599 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.568 168.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.3 -51.5 20.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 122.327 3.064 . . . . 0.0 110.054 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.411 HD22 ' CD1' ' A' ' 161' ' ' PHE . 27.4 tp -78.93 -3.14 43.37 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 126.828 2.58 . . . . 0.0 115.401 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 15.4 t -130.99 -36.08 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 119.213 -2.179 . . . . 0.0 114.158 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . 0.282 . . -91.41 -48.47 6.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 120.21 1.368 . . . . 0.0 108.753 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.76 -47.71 86.93 Favored Glycine 0 C--O 1.188 -2.757 0 N-CA-C 106.237 -2.745 . . . . 0.0 106.237 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.72 -54.37 7.98 Favored 'General case' 0 C--O 1.196 -1.72 1 O-C-N 115.533 -4.51 . . . . 0.0 117.79 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -46.32 -50.73 15.91 Favored 'General case' 0 CA--C 1.475 -1.94 0 O-C-N 116.576 -3.827 . . . . 0.0 112.84 164.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.0 m -63.9 -50.45 68.69 Favored 'General case' 0 N--CA 1.406 -2.672 1 O-C-N 115.213 -4.679 . . . . 0.0 110.829 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.3 p -78.33 -33.58 49.13 Favored 'General case' 0 C--O 1.185 -2.307 0 CA-C-O 116.533 -1.698 . . . . 0.0 113.838 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 12.0 m -54.13 -58.76 6.14 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 116.909 -1.519 . . . . 0.0 109.035 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 2.3 m -63.12 -42.82 99.6 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 116.752 2.131 . . . . 0.0 116.752 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -57.49 -38.73 75.06 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 125.393 1.477 . . . . 0.0 112.109 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.32 -44.52 80.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.91 68.13 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.965 1.257 . . . . 0.0 113.661 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -60.6 -58.9 6.51 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.152 162.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -56.95 -45.48 82.79 Favored 'General case' 0 CA--C 1.613 3.376 0 O-C-N 119.088 -2.258 . . . . 0.0 115.317 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.76 -10.96 11.12 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.112 0 CA-C-O 113.15 -3.31 . . . . 0.0 110.146 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.56 -35.63 34.1 Favored 'General case' 0 N--CA 1.408 -2.551 1 O-C-N 129.949 4.531 . . . . 0.0 106.234 161.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . 0.252 6.9 tt -57.58 -50.91 71.57 Favored 'General case' 0 CA--C 1.599 2.853 0 CA-C-N 125.879 3.945 . . . . 0.0 110.433 164.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.98 -29.48 63.28 Favored 'General case' 0 CA--C 1.604 3.033 0 CA-C-N 122.071 2.214 . . . . 0.0 113.051 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 15.5 mmt -74.64 -26.73 60.07 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 36.2 p -103.73 -19.83 14.17 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.272 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -102.18 111.42 64.35 Favored Pre-proline 0 N--CA 1.513 2.721 0 CA-C-N 121.972 2.169 . . . . 0.0 112.679 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.25 -34.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.261 1.653 0 CA-C-O 114.679 -2.301 . . . . 0.0 108.678 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.4 -37.16 86.55 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 120.574 1.534 . . . . 0.0 112.719 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -71.62 -39.17 70.61 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.232 1.378 . . . . 0.0 114.105 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -55.91 -32.94 64.21 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 115.635 -2.126 . . . . 0.0 111.371 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -82.13 -37.05 26.83 Favored 'General case' 0 C--O 1.171 -3.03 0 CA-C-O 113.898 -2.954 . . . . 0.0 108.892 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.92 -50.05 73.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 22.5 mt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.228 1.58 . . . . 0.0 112.254 171.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 tp -56.44 -42.07 77.51 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.918 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.302 3.9 t70 -65.02 -37.91 89.19 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 131.138 3.775 . . . . 0.0 114.052 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -142.5 75.06 19.41 Favored Pre-proline 0 N--CA 1.498 1.954 0 CA-C-O 126.587 3.089 . . . . 0.0 109.866 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.68 -14.83 28.28 Favored 'Trans proline' 0 C--O 1.177 -2.548 0 O-C-N 117.165 -2.071 . . . . 0.0 115.874 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.281 1.8 pm0 -72.99 -17.83 61.42 Favored 'General case' 0 CA--C 1.599 2.854 0 O-C-N 117.048 -3.532 . . . . 0.0 113.226 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.85 -24.24 31.0 Favored 'General case' 0 C--O 1.266 1.971 0 CA-C-O 114.244 -2.789 . . . . 0.0 109.001 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 72.2 mt -43.86 -45.74 18.87 Favored Pre-proline 0 C--O 1.191 -2.006 0 CA-C-N 121.278 1.853 . . . . 0.0 114.113 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.51 -30.73 28.6 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 124.459 2.628 . . . . 0.0 111.851 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 51.3 m -69.72 -39.47 76.82 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.786 -1.196 . . . . 0.0 109.131 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.37 83.84 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.11 -51.34 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.06 0 CA-C-O 117.178 -1.391 . . . . 0.0 108.44 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -56.06 -48.77 75.43 Favored 'General case' 0 C--O 1.262 1.752 0 C-N-CA 128.84 2.856 . . . . 0.0 110.264 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . 0.251 47.1 tp10 -65.17 -43.47 91.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 118.92 -2.363 . . . . 0.0 113.955 172.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.95 -26.38 64.36 Favored 'General case' 0 N--CA 1.488 1.453 1 O-C-N 115.445 -4.535 . . . . 0.0 110.959 166.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 23.6 m -76.74 -41.81 43.52 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.524 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -69.05 -10.86 59.68 Favored 'General case' 0 C--O 1.167 -3.25 0 C-N-CA 128.749 2.82 . . . . 0.0 106.355 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -102.17 -31.28 10.66 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 116.752 -3.718 . . . . 0.0 110.715 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 18.8 t -29.14 100.26 0.12 Allowed Pre-proline 0 N--CA 1.518 2.951 0 C-N-CA 125.704 1.601 . . . . 0.0 115.232 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.84 7.21 2.08 Favored 'Trans proline' 0 C--O 1.204 -1.189 1 C-N-CA 125.645 4.23 . . . . 0.0 114.162 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 14.1 tp 53.38 46.62 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 128.721 2.808 . . . . 0.0 113.945 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.07 -79.32 0.01 OUTLIER Glycine 1 CA--C 1.448 -4.151 0 C-N-CA 125.629 1.585 . . . . 0.0 115.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . . . . . . . . . 21.9 m -86.66 -20.73 7.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 O-C-N 117.312 -3.463 . . . . 0.0 112.057 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -6.77 23.65 Favored Glycine 0 N--CA 1.489 2.214 0 CA-C-N 122.795 2.543 . . . . 0.0 115.565 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 310' ' ' SER . 8.9 t -143.94 151.86 40.33 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.898 2.349 . . . . 0.0 108.69 -170.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.38 145.53 43.71 Favored 'General case' 0 CA--C 1.572 1.802 0 O-C-N 128.781 3.8 . . . . 0.0 109.359 161.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.7 164.77 1.06 Allowed Pre-proline 0 CA--C 1.571 1.784 0 C-N-CA 124.398 1.079 . . . . 0.0 112.393 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -80.28 136.81 11.57 Favored 'Trans proline' 0 C--O 1.204 -1.198 0 N-CA-C 107.926 -1.605 . . . . 0.0 107.926 -158.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -108.04 152.69 24.15 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 130.705 3.602 . . . . 0.0 105.551 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -115.94 133.08 56.4 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 119.521 -1.987 . . . . 0.0 109.372 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -74.25 120.65 20.12 Favored 'General case' 0 N--CA 1.412 -2.349 0 O-C-N 118.428 -2.67 . . . . 0.0 105.155 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -84.68 0.53 5.19 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 O-C-N 119.513 -1.992 . . . . 0.0 116.194 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.66 167.12 31.23 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.66 143.85 47.98 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.05 121.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 CA-C-O 123.395 1.569 . . . . 0.0 110.171 -167.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 71.6 p -86.4 143.94 27.56 Favored 'General case' 0 C--O 1.255 1.35 0 O-C-N 116.898 -3.626 . . . . 0.0 111.981 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 61.7 tp -150.11 130.39 13.7 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-O 114.868 -2.491 . . . . 0.0 105.284 -170.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ARG . . . . . . . . . . . . . 71.4 mtt-85 39.46 44.8 1.19 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 66.47 14.4 62.2 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 119.961 2.745 . . . . 0.0 119.961 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.51 138.84 53.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 90.0 m -77.81 130.07 36.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 127.057 2.143 . . . . 0.0 110.785 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 17.7 mt -91.7 136.33 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 127.911 2.484 . . . . 0.0 105.465 161.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -100.56 151.14 21.94 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 126.863 2.065 . . . . 0.0 108.27 -168.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -52.87 118.62 3.82 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.47 39.07 26.95 Favored Glycine 0 C--N 1.391 3.609 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -126.0 137.34 29.94 Favored Pre-proline 0 C--N 1.368 1.379 0 CA-C-O 117.246 -1.359 . . . . 0.0 107.384 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.89 138.96 8.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 124.535 1.808 . . . . 0.0 115.231 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.3 m -123.0 128.24 75.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 126.474 3.035 . . . . 0.0 107.736 167.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 34.9 mt -88.52 145.85 25.5 Favored 'General case' 0 C--O 1.269 2.131 0 CA-C-N 108.735 -3.848 . . . . 0.0 108.342 163.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -117.85 116.67 27.45 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 119.643 -1.91 . . . . 0.0 109.401 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 284' ' ' THR . 33.3 m -77.24 49.38 0.69 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.1 p -51.13 -41.78 60.28 Favored 'General case' 0 C--O 1.189 -2.08 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -166.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.51 85.65 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 125.064 2.48 . . . . 0.0 116.152 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.55 58.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 117.362 -3.434 . . . . 0.0 113.08 171.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.83 -17.9 54.92 Favored 'General case' 0 N--CA 1.42 -1.972 0 O-C-N 126.545 2.403 . . . . 0.0 108.684 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . 0.275 61.6 t30 -70.78 -1.52 11.81 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 119.352 -2.092 . . . . 0.0 110.558 166.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -136.53 16.47 3.14 Favored 'General case' 0 C--N 1.396 2.589 0 O-C-N 117.566 -3.209 . . . . 0.0 111.149 -168.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -68.04 118.57 11.38 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -59.38 -29.72 67.9 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.881 -1.762 . . . . 0.0 111.899 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -86.34 -7.41 58.49 Favored 'General case' 0 CA--C 1.586 2.33 0 O-C-N 125.115 1.509 . . . . 0.0 114.209 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -96.5 -46.49 6.33 Favored 'General case' 0 N--CA 1.493 1.687 1 CA-C-O 110.389 -4.624 . . . . 0.0 110.71 154.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -120.8 155.65 57.09 Favored Pre-proline 0 C--N 1.393 2.484 1 CA-C-N 129.036 5.38 . . . . 0.0 111.208 -170.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -78.9 130.07 9.34 Favored 'Trans proline' 0 CA--C 1.584 3.009 0 N-CA-C 104.807 -2.805 . . . . 0.0 104.807 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.03 52.38 13.18 Favored 'General case' 0 CA--C 1.575 1.921 0 CA-C-O 124.999 2.333 . . . . 0.0 112.628 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.18 -26.29 52.75 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-O 125.673 2.654 . . . . 0.0 110.974 -147.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.77 -23.63 67.3 Favored 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 128.515 2.726 . . . . 0.0 115.343 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -101.93 169.38 8.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.785 2.834 . . . . 0.0 111.016 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.7 pt -95.63 151.23 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 O-C-N 125.138 1.524 . . . . 0.0 113.215 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -137.82 87.61 2.26 Favored 'General case' 0 CA--C 1.627 3.932 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.158 162.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.92 -6.89 0.99 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.247 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.87 -7.3 53.08 Favored 'General case' 0 N--CA 1.501 2.093 1 O-C-N 115.841 -4.287 . . . . 0.0 112.641 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -73.65 114.51 11.99 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.913 2.085 . . . . 0.0 113.638 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.8 t -166.93 135.84 2.25 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.439 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.17 165.3 32.25 Favored 'Cis proline' 0 C--N 1.301 -1.957 0 O-C-N 123.713 1.375 . . . . 0.0 110.152 -2.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -131.13 157.75 42.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 126.108 1.763 . . . . 0.0 113.898 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.36 157.46 37.15 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 127.24 2.216 . . . . 0.0 109.029 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -153.68 162.56 41.14 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 114.359 -2.734 . . . . 0.0 113.874 -155.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LEU . . . . . . . . . . . . . 46.0 tp -135.22 -2.32 2.53 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -71.56 28.93 0.6 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 126.771 2.129 . . . . 0.0 115.067 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -145.28 11.68 1.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 118.543 1.172 . . . . 0.0 111.293 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 96.69 -177.95 33.42 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 119.021 -1.561 . . . . 0.0 114.104 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -157.97 145.69 18.48 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 118.371 -2.84 . . . . 0.0 112.321 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 59.3 -115.41 7.35 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 117.521 -1.711 . . . . 0.0 110.507 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 35.6 m -94.77 23.23 0.7 Allowed 'Isoleucine or valine' 1 N--CA 1.554 4.728 0 CA-C-N 122.989 3.394 . . . . 0.0 115.916 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -129.31 50.97 2.1 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.94 1.4 . . . . 0.0 112.747 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' HIS . . . . . . . . . . . . 0.283 40.1 p-80 -121.88 153.07 38.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.603 1.561 . . . . 0.0 113.707 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' CYS . . . . . . . . . . . . 0.25 6.8 t -48.45 148.74 1.85 Allowed 'General case' 0 CA--C 1.569 1.692 1 O-C-N 130.668 4.98 . . . . 0.0 113.405 162.086 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 19.9 tp -83.21 -33.31 26.16 Favored 'General case' 0 C--O 1.3 3.718 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.404 ' HA3' ' C1C' ' A' ' 401' ' ' HEM . . . -65.97 -23.04 70.92 Favored Glycine 0 CA--C 1.548 2.155 0 C-N-CA 130.047 3.689 . . . . 0.0 121.575 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.54 47.52 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -160.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.37 -32.53 96.75 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 115.904 -2.264 . . . . 0.0 114.043 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.67 -48.86 62.88 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 117.857 -3.027 . . . . 0.0 112.323 169.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.846 -170.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ARG . . . . . . . . . . . . 0.269 12.6 ttt180 -55.51 -40.56 71.94 Favored 'General case' 0 N--CA 1.388 -3.556 0 O-C-N 117.293 -3.379 . . . . 0.0 113.704 160.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 -39.29 27.92 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 114.75 -2.548 . . . . 0.0 109.377 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.47 -62.35 1.78 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 128.014 3.769 . . . . 0.0 115.622 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 71.6 mt -48.33 -32.43 7.41 Favored 'General case' 0 C--O 1.176 -2.791 1 O-C-N 112.474 -6.391 . . . . 0.0 114.73 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -82.56 -49.62 9.68 Favored 'General case' 0 CA--C 1.603 2.989 0 C-N-CA 116.17 -2.212 . . . . 0.0 111.036 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.9 -42.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 O-C-N 124.591 1.182 . . . . 0.0 110.402 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.03 -21.44 64.11 Favored 'General case' 0 CA--C 1.612 3.356 0 O-C-N 118.588 -2.57 . . . . 0.0 115.599 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 16.4 mt -92.09 -34.06 14.53 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 127.813 2.445 . . . . 0.0 110.245 166.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' GLU . . . . . 0.409 ' CD ' HH11 ' A' ' 115' ' ' ARG . 38.3 tt0 -61.04 -67.95 0.36 Allowed 'General case' 0 N--CA 1.391 -3.416 0 CA-C-O 126.295 2.95 . . . . 0.0 112.391 -175.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.2 t -81.42 -15.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 CA-C-N 111.187 -2.733 . . . . 0.0 107.981 -161.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.83 -50.27 72.96 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-N 121.477 1.944 . . . . 0.0 110.806 168.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.12 -10.19 59.76 Favored 'General case' 0 C--N 1.375 1.688 0 O-C-N 119.738 -1.851 . . . . 0.0 114.012 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -75.76 -42.11 51.25 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-O 117.037 -1.459 . . . . 0.0 112.457 163.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -105.54 -25.98 12.08 Favored 'General case' 0 CA--C 1.582 2.176 0 CA-C-O 115.895 -2.002 . . . . 0.0 114.778 -161.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' LEU . . . . . . . . . . . . . 34.2 tp -160.36 47.25 0.23 Allowed Pre-proline 0 CA--C 1.572 1.795 0 O-C-N 125.234 1.584 . . . . 0.0 109.82 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -46.15 -18.41 0.42 Allowed 'Trans proline' 0 N--CA 1.482 0.801 0 CA-C-O 111.618 -3.576 . . . . 0.0 113.798 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.84 -16.87 48.5 Favored Glycine 0 CA--C 1.564 3.131 1 CA-C-N 127.683 4.765 . . . . 0.0 113.4 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 17.6 tt -55.29 144.34 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.618 3.563 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -161.79 169.96 20.43 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 130.237 3.415 . . . . 0.0 107.562 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 14.5 tp -74.44 122.84 23.64 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.388 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -84.89 15.94 40.01 Favored Glycine 0 C--O 1.189 -2.684 0 CA-C-O 116.094 -2.503 . . . . 0.0 114.194 -167.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 17.3 pt -144.65 169.24 10.4 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.508 -2.663 . . . . 0.0 112.556 -167.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -63.06 142.68 88.46 Favored 'Trans proline' 0 N--CA 1.416 -3.088 0 CA-C-N 121.775 1.67 . . . . 0.0 108.051 159.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -70.79 -13.8 62.18 Favored 'General case' 0 C--N 1.388 2.268 0 C-N-CA 115.748 -2.381 . . . . 0.0 112.652 -148.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 41.7 p -90.63 -15.45 30.45 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 119.488 -2.007 . . . . 0.0 107.926 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . 0.276 28.4 mt-30 -89.78 64.39 6.43 Favored 'General case' 0 C--O 1.273 2.332 1 O-C-N 115.553 -4.467 . . . . 0.0 113.611 -156.223 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.13 173.13 6.47 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 124.013 1.864 . . . . 0.0 112.947 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ARG . . . . . 0.438 HH22 ' CD ' ' A' ' 173' ' ' GLU . 34.4 ttp85 -108.48 136.78 47.53 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.994 -1.066 . . . . 0.0 109.717 167.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -105.17 154.46 20.16 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -165.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' SER . . . . . . . . . . . . 0.323 59.1 m -85.31 104.75 15.42 Favored 'General case' 1 N--CA 1.548 4.466 0 C-N-CA 127.425 2.29 . . . . 0.0 114.062 172.665 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.92 33.62 2.53 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -75.52 0.55 60.29 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 119.212 -2.18 . . . . 0.0 117.575 -173.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' MET . . . . . . . . . . . . 0.359 8.1 tpt 69.74 31.15 3.63 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-O 116.067 -1.921 . . . . 0.0 113.168 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.52 -35.45 0.9 Allowed 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 121.445 1.93 . . . . 0.0 114.411 145.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 11.4 mt -119.65 149.79 41.39 Favored 'General case' 0 CA--C 1.462 -2.435 0 C-N-CA 125.601 1.56 . . . . 0.0 113.882 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -117.68 146.02 44.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 124.068 3.122 . . . . 0.0 114.313 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 173.74 169.27 35.84 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.158 -1.589 . . . . 0.0 110.867 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.96 155.1 69.92 Favored 'Trans proline' 0 N--CA 1.521 3.1 0 C-N-CA 125.164 3.909 . . . . 0.0 110.394 169.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.01 -41.84 7.79 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 125.293 2.473 . . . . 0.0 112.695 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -123.39 147.0 47.54 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.985 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' LEU . . . . . . . . . . . . . 5.3 tp -142.76 86.96 9.25 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 125.051 1.34 . . . . 0.0 111.355 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.9 137.9 50.84 Favored 'Trans proline' 0 C--N 1.363 1.338 0 N-CA-C 116.913 1.851 . . . . 0.0 116.913 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.59 150.61 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 125.866 1.979 . . . . 0.0 114.542 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.14 157.04 43.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 O-C-N 127.747 3.154 . . . . 0.0 110.592 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' TRP . . . . . . . . . . . . . 32.8 p90 . . . . . 0 CA--C 1.493 -1.249 1 O-C-N 115.229 -4.669 . . . . 0.0 110.763 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' HEM . . . . . 0.404 ' C1C' ' HA3' ' A' ' 348' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' MIV . . . . . 0.432 ' H11' ' C5 ' ' A' ' 402' ' ' MIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 115.085 -2.388 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.47 166.65 18.94 Favored 'Trans proline' 0 C--O 1.264 1.816 0 CA-C-N 125.179 2.885 . . . . 0.0 111.736 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -110.71 149.73 30.06 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.06 115.62 20.6 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 127.719 2.408 . . . . 0.0 109.625 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 10.3 t80 -101.94 150.49 37.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 127.205 2.202 . . . . 0.0 108.103 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.579 ' HA ' ' CG ' ' A' ' 9' ' ' TYR . 30.0 Cg_exo -72.69 160.21 95.42 Favored 'Cis proline' 0 C--N 1.399 3.228 0 CA-C-O 125.783 2.326 . . . . 0.0 114.327 -1.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -95.85 -33.43 12.23 Favored 'General case' 1 C--O 1.309 4.232 0 O-C-N 118.428 -2.67 . . . . 0.0 110.029 174.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -65.36 171.55 3.83 Favored 'General case' 0 N--CA 1.512 2.672 1 O-C-N 116.248 -4.032 . . . . 0.0 111.336 151.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -157.99 144.77 17.8 Favored 'General case' 1 C--O 1.312 4.346 0 O-C-N 119.774 -1.829 . . . . 0.0 111.284 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -50.18 -33.89 10.31 Favored 'Isoleucine or valine' 0 C--N 1.377 1.779 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.6 73.86 9.34 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 117.66 -3.15 . . . . 0.0 114.163 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.27 177.22 42.47 Favored Glycine 0 N--CA 1.487 2.083 1 CA-C-O 113.299 -4.056 . . . . 0.0 114.692 167.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.311 13.1 mt -128.6 -37.73 1.76 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 175.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -92.65 -178.75 4.96 Favored 'General case' 0 C--O 1.268 2.029 0 C-N-CA 114.992 -2.683 . . . . 0.0 109.093 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -63.68 121.3 13.62 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 118.359 -2.713 . . . . 0.0 109.184 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . 0.277 . . -58.8 131.52 51.19 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -173.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.94 -31.63 58.66 Favored Glycine 0 CA--C 1.558 2.749 0 O-C-N 119.317 -2.115 . . . . 0.0 115.985 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -72.53 -20.59 61.32 Favored 'General case' 0 C--O 1.262 1.762 0 CA-C-O 116.158 -1.877 . . . . 0.0 110.478 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -53.43 7.84 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.92 -12.2 67.65 Favored Glycine 0 CA--C 1.564 3.132 0 O-C-N 118.991 -2.318 . . . . 0.0 113.519 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -92.34 -26.35 18.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 120.251 -1.735 . . . . 0.0 110.067 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.79 -30.05 29.14 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-N 120.899 1.682 . . . . 0.0 110.722 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -53.96 -24.22 15.8 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 116.311 -1.804 . . . . 0.0 115.247 160.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -98.02 -35.11 10.54 Favored 'General case' 0 C--N 1.393 2.49 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -104.97 -7.57 19.18 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.2 75.88 10.46 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-O 128.428 3.966 . . . . 0.0 116.515 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -70.37 -12.37 31.63 Favored 'Trans proline' 0 C--O 1.189 -1.962 0 O-C-N 113.813 -3.835 . . . . 0.0 115.632 -158.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.95 118.11 27.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.277 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 154.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 m -100.4 158.42 15.91 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-O 113.774 -3.012 . . . . 0.0 117.593 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -88.08 136.44 32.97 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 127.284 2.865 . . . . 0.0 106.042 156.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.61 147.18 33.3 Favored 'Isoleucine or valine' 0 C--O 1.254 1.313 0 O-C-N 128.042 3.339 . . . . 0.0 110.166 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -111.28 112.79 54.58 Favored Pre-proline 0 C--O 1.267 1.982 0 C-N-CA 129.271 3.028 . . . . 0.0 106.442 155.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -73.68 -171.78 0.93 Allowed 'Trans proline' 0 N--CA 1.418 -2.926 0 CA-C-O 128.649 3.521 . . . . 0.0 109.12 159.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -87.52 -23.16 1.44 Allowed 'Trans proline' 1 CA--C 1.625 5.026 0 O-C-N 114.254 -3.603 . . . . 0.0 109.985 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.1 133.66 50.38 Favored 'General case' 0 CA--C 1.484 -1.563 0 O-C-N 117.393 -3.317 . . . . 0.0 114.767 172.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 176.53 22.28 Favored Glycine 0 N--CA 1.493 2.488 1 O-C-N 114.382 -5.199 . . . . 0.0 112.415 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.65 176.32 5.62 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 127.421 3.486 . . . . 0.0 111.928 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.02 152.9 36.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 118.039 -2.913 . . . . 0.0 109.871 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.27 165.57 27.11 Favored 'General case' 0 C--O 1.178 -2.699 0 CA-C-O 124.838 2.256 . . . . 0.0 114.284 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -84.18 149.89 25.86 Favored 'General case' 0 CA--C 1.558 1.271 0 O-C-N 120.528 -1.357 . . . . 0.0 108.627 162.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.13 112.21 13.74 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.248 -0.907 . . . . 0.0 111.983 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.08 132.13 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.049 0 C-N-CA 128.282 2.633 . . . . 0.0 110.622 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.5 p -121.17 -27.39 4.91 Favored 'General case' 0 CA--C 1.561 1.367 1 C-N-CA 132.324 4.249 . . . . 0.0 116.851 -160.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 mmm-85 -100.29 147.41 25.8 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.4 -167.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -49.1 -62.64 1.43 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 124.291 1.996 . . . . 0.0 108.165 -169.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.275 70.0 mm-40 -76.01 -9.81 58.92 Favored 'General case' 0 C--O 1.192 -1.966 0 CA-C-O 123.771 1.748 . . . . 0.0 114.269 -170.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.58 -32.77 25.6 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 117.719 -3.113 . . . . 0.0 109.838 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.42 -36.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 O-C-N 118.359 -2.713 . . . . 0.0 109.648 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -57.59 -29.42 64.46 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 116.644 -1.646 . . . . 0.0 112.548 162.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 -50.29 22.47 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 168.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.08 -25.05 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.186 0 CA-C-N 119.835 1.198 . . . . 0.0 110.232 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -98.39 35.42 1.79 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-O 124.55 2.119 . . . . 0.0 110.023 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.92 23.69 0.47 Allowed Glycine 0 C--N 1.292 -1.891 0 O-C-N 117.478 -3.264 . . . . 0.0 119.071 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -138.44 135.77 35.55 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 120.174 1.987 . . . . 0.0 108.456 168.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.96 -14.63 53.55 Favored Glycine 0 C--O 1.188 -2.779 0 CA-C-O 116.528 -2.262 . . . . 0.0 114.702 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -84.53 -3.52 58.46 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.54 ' CE2' ' HB2' ' A' ' 290' ' ' ALA . 46.4 m-85 -99.44 121.71 41.51 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 119.575 1.08 . . . . 0.0 111.994 160.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.94 167.15 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 124.755 1.222 . . . . 0.0 113.475 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -80.04 -21.38 43.54 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 115.538 -2.172 . . . . 0.0 113.407 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.53 -45.21 93.36 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-N 122.529 2.422 . . . . 0.0 117.148 -150.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.59 -27.65 8.0 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 124.037 3.158 . . . . 0.0 115.868 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.0 p -50.46 -20.4 1.12 Allowed 'General case' 0 C--O 1.298 3.628 0 CA-C-N 124.04 3.109 . . . . 0.0 113.469 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -10.22 59.25 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 119.908 -1.745 . . . . 0.0 112.871 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.5 p -138.96 18.56 2.64 Favored 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.827 0.823 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.251 22.1 mtp180 -135.92 151.92 50.46 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 118.726 -2.484 . . . . 0.0 108.784 167.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -72.08 106.4 4.31 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.743 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.05 138.67 30.79 Favored Pre-proline 0 CA--C 1.491 -1.303 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -158.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.87 104.13 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-O 116.917 -1.368 . . . . 0.0 114.829 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -145.79 168.71 20.1 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 125.958 1.703 . . . . 0.0 112.412 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 282' ' ' VAL . 27.5 p -88.67 -8.37 54.7 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 119.919 3.303 . . . . 0.0 119.919 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -126.34 156.49 72.52 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 117.217 -3.427 . . . . 0.0 116.394 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.74 -49.35 4.27 Favored 'Trans proline' 1 N--CA 1.397 -4.159 1 C-N-CA 127.88 5.72 . . . . 0.0 111.404 -166.318 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -72.71 152.77 41.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.5 mtt -76.88 155.58 32.77 Favored 'General case' 0 CA--C 1.56 1.353 0 O-C-N 119.879 -1.763 . . . . 0.0 108.897 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.2 t -67.09 94.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 124.827 2.251 . . . . 0.0 108.737 166.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.312 43.4 mmtt -105.94 -19.62 13.68 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 117.482 -3.261 . . . . 0.0 116.755 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.76 143.32 14.95 Favored Glycine 0 N--CA 1.506 3.326 0 CA-C-N 125.291 3.678 . . . . 0.0 116.344 -171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.61 159.97 22.11 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 127.327 3.737 . . . . 0.0 109.979 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -42.38 -28.43 0.21 Allowed 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 119.872 3.286 . . . . 0.0 119.872 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 tp -78.04 -0.69 28.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.49 -1.381 . . . . 0.0 113.53 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -88.92 19.59 4.03 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 123.596 1.665 . . . . 0.0 114.04 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.5 mtt -149.34 159.3 44.4 Favored 'General case' 0 N--CA 1.525 3.315 0 O-C-N 117.304 -3.372 . . . . 0.0 111.358 -158.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -142.91 151.12 55.52 Favored Pre-proline 0 C--N 1.363 1.184 0 O-C-N 117.71 -3.119 . . . . 0.0 112.729 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -64.31 144.98 87.72 Favored 'Trans proline' 0 C--O 1.274 2.313 0 C-N-CA 124.626 3.551 . . . . 0.0 116.337 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.15 -14.16 25.92 Favored 'Cis proline' 1 N--CA 1.547 4.625 0 O-C-N 125.271 2.195 . . . . 0.0 115.223 5.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.81 -26.32 68.29 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 118.889 -2.382 . . . . 0.0 116.632 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -77.25 -37.71 52.57 Favored 'General case' 0 C--O 1.262 1.745 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -62.27 -46.68 87.71 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . 0.412 0.1 OUTLIER -58.5 -33.13 69.46 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 119.871 -1.768 . . . . 0.0 109.567 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -51.0 10.13 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 117.013 -1.875 . . . . 0.0 113.771 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.15 -45.98 91.22 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 114.401 -2.714 . . . . 0.0 115.877 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -46.46 -36.25 6.42 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 125.349 3.704 . . . . 0.0 116.32 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 219' ' ' LEU 0.348 1.3 tt -74.26 -60.1 2.42 Favored 'General case' 0 CA--C 1.616 3.487 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.755 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.27 22.9 m -65.33 -28.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 114.077 -2.868 . . . . 0.0 109.045 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.0 m -68.39 -20.98 25.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 121.42 1.918 . . . . 0.0 115.737 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -76.75 -22.54 53.65 Favored 'General case' 0 N--CA 1.527 3.383 0 CA-C-O 115.643 -2.123 . . . . 0.0 111.593 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.3 -34.9 3.94 Favored 'General case' 0 C--O 1.272 2.239 0 CA-C-N 120.245 1.384 . . . . 0.0 111.368 -170.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -73.74 48.03 0.27 Allowed 'General case' 0 CA--C 1.564 1.491 0 O-C-N 118.461 -2.649 . . . . 0.0 110.49 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -69.69 157.18 37.76 Favored 'General case' 0 CA--C 1.569 1.7 1 N-CA-C 123.472 4.619 . . . . 0.0 123.472 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.68 -29.34 61.19 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.61 2.444 . . . . 0.0 113.401 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.322 16.7 ttt-85 -61.38 -51.26 69.51 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 167.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -55.52 -36.5 66.8 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.831 1.252 . . . . 0.0 112.989 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . 0.357 . . -59.18 -54.34 48.01 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.25 4.5 tp10 -49.06 -46.59 44.66 Favored 'General case' 0 CA--C 1.6 2.886 0 CA-C-O 121.821 0.82 . . . . 0.0 112.802 171.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.5 m -76.75 5.5 7.58 Favored 'General case' 0 C--O 1.278 2.604 0 O-C-N 121.372 -0.83 . . . . 0.0 112.865 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.48 -26.58 14.4 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 124.086 0.954 . . . . 0.0 113.09 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -48.94 -42.0 57.14 Favored Pre-proline 1 CA--C 1.665 5.397 0 CA-C-O 112.937 -3.411 . . . . 0.0 111.427 -174.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -58.56 -49.91 10.75 Favored 'Trans proline' 1 CA--C 1.604 4.002 0 O-C-N 124.814 1.955 . . . . 0.0 109.532 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -68.78 -33.38 73.79 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -33.08 72.46 Favored 'General case' 0 C--O 1.176 -2.804 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.585 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.7 mtt180 -73.86 -36.69 64.87 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 117.673 -3.142 . . . . 0.0 107.814 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.36 -25.12 60.46 Favored 'General case' 0 C--O 1.254 1.319 0 O-C-N 125.636 1.835 . . . . 0.0 113.519 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.276 24.0 mt -66.51 -63.48 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 160.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.88 -44.51 39.99 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -66.56 -33.73 76.33 Favored 'General case' 0 C--O 1.254 1.314 0 O-C-N 118.136 -2.852 . . . . 0.0 111.7 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -72.74 -41.98 64.58 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 117.15 -3.469 . . . . 0.0 108.794 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.5 -36.15 79.68 Favored 'General case' 0 C--O 1.26 1.612 0 O-C-N 116.665 -3.772 . . . . 0.0 108.431 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.9 t -79.93 -30.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 117.964 -2.96 . . . . 0.0 113.969 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -61.76 -48.54 80.23 Favored 'General case' 0 CA--C 1.615 3.456 0 C-N-CA 126.029 1.732 . . . . 0.0 109.304 168.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.75 -31.69 68.59 Favored 'General case' 0 N--CA 1.537 3.885 0 O-C-N 118.373 -2.704 . . . . 0.0 110.457 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.9 ttp -61.19 -53.66 54.15 Favored 'General case' 0 C--O 1.259 1.604 0 O-C-N 116.391 -3.943 . . . . 0.0 110.617 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.77 -49.16 71.56 Favored 'General case' 0 C--O 1.256 1.442 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.104 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . 0.343 . . -64.65 -18.94 65.41 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 129.526 3.131 . . . . 0.0 117.975 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 m -84.46 -21.92 30.5 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 114.828 -2.51 . . . . 0.0 111.026 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.53 179.55 49.56 Favored Glycine 1 N--CA 1.544 5.853 0 CA-C-N 122.576 2.444 . . . . 0.0 112.155 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.28 157.59 53.06 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 127.379 2.458 . . . . 0.0 114.08 -169.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 395' ' ' VAL . 30.0 Cg_endo -67.27 159.1 81.9 Favored 'Cis proline' 0 C--O 1.287 2.963 0 O-C-N 123.719 1.378 . . . . 0.0 110.23 -7.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.77 161.22 21.83 Favored 'General case' 0 CA--C 1.586 2.335 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.091 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -93.11 114.3 26.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.399 1.0 . . . . 0.0 112.402 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . 0.284 11.8 tp -72.73 -14.36 61.54 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 114.218 -1.356 . . . . 0.0 113.835 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.65 -44.73 20.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 1 O-C-N 115.373 -4.579 . . . . 0.0 110.239 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.9 -33.29 62.02 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.494 -1.682 . . . . 0.0 107.457 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.0 mtt -100.66 -6.54 25.01 Favored 'General case' 0 C--O 1.201 -1.476 0 O-C-N 119.07 -2.269 . . . . 0.0 110.904 -171.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -135.08 -69.3 0.51 Allowed 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.22 -29.0 67.2 Favored 'General case' 0 CA--C 1.594 2.638 1 O-C-N 115.834 -4.291 . . . . 0.0 114.407 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.48 -18.06 57.46 Favored 'General case' 1 N--CA 1.556 4.837 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . 0.258 50.1 mm-40 -114.13 -15.4 12.24 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 114.536 -2.649 . . . . 0.0 113.905 -164.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 143' ' ' PRO . 22.7 tp -80.48 -50.91 1.06 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 111.746 -3.978 . . . . 0.0 108.716 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 142' ' ' LEU . 71.7 Cg_exo -57.9 -52.75 5.37 Favored 'Trans proline' 0 N--CA 1.518 2.931 0 CA-C-N 125.137 2.87 . . . . 0.0 110.892 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.4 -33.08 61.12 Favored 'Isoleucine or valine' 0 C--O 1.27 2.164 0 CA-C-O 114.649 -2.595 . . . . 0.0 107.515 -160.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.291 64.6 mtt180 -71.91 -49.64 36.0 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 126.804 2.565 . . . . 0.0 114.768 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.72 -48.49 77.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 120.856 1.662 . . . . 0.0 109.63 171.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.69 -32.54 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 128.294 2.638 . . . . 0.0 107.751 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.7 m -78.1 -23.05 48.07 Favored 'General case' 0 C--O 1.187 -2.214 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -67.95 -53.57 25.26 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 110.347 -3.115 . . . . 0.0 110.391 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.5 tp -48.72 -26.03 2.11 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.96 -6.03 36.5 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 121.064 -1.023 . . . . 0.0 113.57 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.85 62.06 Favored Glycine 0 C--O 1.272 2.488 0 C-N-CA 127.835 2.636 . . . . 0.0 111.065 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.7 t -82.78 136.52 44.66 Favored Pre-proline 0 C--O 1.2 -1.525 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.859 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . 0.392 27.4 Cg_exo -51.41 139.09 46.47 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 C-N-CA 122.568 2.179 . . . . 0.0 116.693 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 84.7 p -57.11 -36.65 70.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.54 65.04 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -97.59 -6.13 34.05 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.022 -1.673 . . . . 0.0 114.524 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -60.92 -26.75 67.7 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 116.516 -2.074 . . . . 0.0 112.566 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -57.33 -53.29 59.85 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 117.947 -2.971 . . . . 0.0 111.822 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -56.24 -55.39 33.89 Favored 'General case' 0 C--N 1.385 2.109 0 C-N-CA 121.228 -0.189 . . . . 0.0 110.527 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.473 ' CD1' HD21 ' A' ' 232' ' ' LEU . 18.1 m-85 -53.36 -34.15 56.46 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 118.807 2.891 . . . . 0.0 118.807 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 91.4 m -56.84 -57.22 13.43 Favored 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.219 1.009 . . . . 0.0 108.541 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 43.5 ttm105 -63.8 -28.38 69.82 Favored 'General case' 0 C--N 1.393 2.482 0 C-N-CA 128.591 2.756 . . . . 0.0 114.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TRP . . . . . . . . . . . . 0.301 46.3 m0 -76.02 -63.88 1.22 Allowed 'General case' 0 N--CA 1.433 -1.325 0 O-C-N 118.555 -2.591 . . . . 0.0 114.325 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.7 m -57.28 -38.45 73.93 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.917 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.4 61.53 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 129.521 3.438 . . . . 0.0 113.706 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.25 38.38 Favored 'General case' 0 C--N 1.282 -2.348 1 O-C-N 115.191 -4.711 . . . . 0.0 110.994 175.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -84.28 -14.6 49.35 Favored 'General case' 0 CA--C 1.603 3.015 0 CA-C-N 122.415 2.371 . . . . 0.0 115.159 162.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.21 143.13 35.65 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 119.898 -1.751 . . . . 0.0 110.637 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 71.9 m -79.34 -27.76 42.05 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.239 166.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.68 5.91 12.1 Favored 'General case' 0 C--O 1.264 1.832 0 CA-C-N 121.981 2.173 . . . . 0.0 114.71 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -140.24 163.69 32.09 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 117.598 -3.189 . . . . 0.0 113.878 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' CD ' HH22 ' A' ' 380' ' ' ARG . 40.5 mt-10 -126.84 83.98 2.22 Favored 'General case' 0 CA--C 1.609 3.222 0 CA-C-O 125.389 2.519 . . . . 0.0 109.875 -171.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 178' ' ' GLU . 20.3 t -124.08 158.75 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 O-C-N 117.592 -3.192 . . . . 0.0 111.768 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 p -97.77 175.64 6.1 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 125.701 2.667 . . . . 0.0 108.825 -165.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.372 1.562 0 O-C-N 119.75 -1.844 . . . . 0.0 109.45 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.06 -22.95 65.07 Favored 'General case' 0 CA--C 1.461 -2.451 0 O-C-N 116.994 -3.566 . . . . 0.0 111.875 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.493 ' HG2' ' CG1' ' A' ' 174' ' ' VAL . 9.2 mp0 -85.97 -31.3 22.15 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-O 114.02 -2.895 . . . . 0.0 110.852 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 61.1 mtm -60.43 -36.31 77.89 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 125.985 3.993 . . . . 0.0 110.736 170.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.49 -39.76 95.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.505 3.122 . . . . 0.0 109.49 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -65.61 -48.53 71.94 Favored 'General case' 0 C--N 1.38 1.913 0 O-C-N 118.344 -2.723 . . . . 0.0 113.763 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.21 86.88 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.05 -27.52 60.96 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.03 -46.85 14.4 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.275 2.23 . . . . 0.0 114.197 175.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -108.93 -15.45 14.37 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 118.861 2.912 . . . . 0.0 118.861 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . 0.259 . . -92.75 -35.13 13.61 Favored 'General case' 0 CA--C 1.486 -1.515 1 O-C-N 115.048 -4.783 . . . . 0.0 111.034 -166.301 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.11 -30.1 62.16 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.92 -38.55 64.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 124.445 1.09 . . . . 0.0 112.75 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.64 -33.8 76.73 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 12.0 tpp -75.62 -31.75 60.0 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.075 -1.85 . . . . 0.0 113.102 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.42 77.65 Favored Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -44.88 -41.48 7.17 Favored 'General case' 0 CA--C 1.619 3.615 0 O-C-N 119.053 -2.439 . . . . 0.0 110.538 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 193' ' ' LEU . 19.5 tp -84.25 -37.17 22.09 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 117.763 -3.086 . . . . 0.0 113.705 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.14 -46.68 84.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 125.048 1.339 . . . . 0.0 108.476 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 120.741 1.61 . . . . 0.0 109.494 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -51.41 -44.8 62.36 Favored 'General case' 0 C--N 1.395 2.553 0 CA-C-O 125.761 2.696 . . . . 0.0 112.887 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -71.62 -27.63 63.23 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 118.809 -2.432 . . . . 0.0 112.083 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -72.36 -49.99 30.0 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 122.573 1.178 . . . . 0.0 109.354 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -48.55 -53.21 19.11 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.27 -2.241 . . . . 0.0 111.906 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -146.45 115.01 4.5 Favored Pre-proline 0 CA--C 1.595 2.69 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.38 144.72 29.37 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 O-C-N 117.113 -2.098 . . . . 0.0 113.179 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -146.48 179.48 7.51 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 127.871 2.468 . . . . 0.0 107.574 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.36 -4.11 59.11 Favored 'General case' 0 C--N 1.377 1.793 0 O-C-N 117.302 -3.374 . . . . 0.0 112.45 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.07 166.53 5.8 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 119.293 -2.129 . . . . 0.0 114.788 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.67 -43.95 79.0 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 118.685 0.675 . . . . 0.0 112.436 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.412 HG13 HD22 ' A' ' 224' ' ' LEU . 2.5 t -56.69 -36.01 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.2 m -62.37 -46.25 89.48 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 126.855 2.062 . . . . 0.0 115.727 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.52 -29.81 70.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.1 1.5 . . . . 0.0 109.927 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.72 -30.54 23.04 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.157 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.458 4.9 m -69.42 -12.03 15.55 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 119.849 3.277 . . . . 0.0 119.849 158.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -106.78 -36.44 6.68 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-N 119.538 1.063 . . . . 0.0 109.934 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.2 149.89 42.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -134.79 154.22 51.7 Favored 'General case' 0 C--O 1.247 0.969 1 CA-C-O 110.409 -4.615 . . . . 0.0 111.234 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -93.09 107.07 18.94 Favored 'General case' 0 C--N 1.248 -3.82 1 O-C-N 129.978 4.549 . . . . 0.0 110.019 162.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 60.74 -92.25 0.03 OUTLIER 'General case' 0 C--O 1.168 -3.222 0 O-C-N 126.891 2.62 . . . . 0.0 109.752 -164.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -129.26 5.71 5.29 Favored 'General case' 0 C--O 1.177 -2.742 0 CA-C-N 120.45 1.477 . . . . 0.0 109.937 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.38 140.95 55.86 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 121.041 1.746 . . . . 0.0 114.868 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.6 m -113.72 131.37 56.2 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 123.927 1.823 . . . . 0.0 111.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 97' ' ' LEU . 13.3 tp -70.46 106.1 3.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.866 -2.425 . . . . 0.0 110.646 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 37.0 m -73.4 169.34 17.36 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 117.375 -3.328 . . . . 0.0 113.704 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -43.31 52.41 Favored 'General case' 0 C--O 1.19 -2.065 0 O-C-N 126.032 2.082 . . . . 0.0 114.917 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.2 -39.07 82.54 Favored 'General case' 0 C--O 1.272 2.277 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.636 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.78 -29.7 69.72 Favored 'General case' 0 C--N 1.378 1.828 0 C-N-CA 126.911 2.084 . . . . 0.0 116.007 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD22 HG13 ' A' ' 206' ' ' VAL . 1.6 tt -93.69 -41.53 9.65 Favored 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 125.784 1.634 . . . . 0.0 109.88 -176.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 47.6 tp -51.93 -51.95 53.47 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.484 -0.76 . . . . 0.0 112.436 160.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.8 -58.6 6.66 Favored 'General case' 0 C--O 1.267 1.976 0 O-C-N 117.929 -2.982 . . . . 0.0 113.705 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.86 -51.55 39.34 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.072 0.939 . . . . 0.0 111.514 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.41 93.48 Favored 'General case' 0 CA--C 1.587 2.376 0 CA-C-N 111.993 -2.367 . . . . 0.0 115.854 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 229' ' ' ILE . 4.7 tp -62.46 -49.77 82.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.703 0 O-C-N 119.836 -1.79 . . . . 0.0 108.98 172.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -51.09 -36.37 35.1 Favored Glycine 0 C--N 1.373 2.599 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.568 168.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.3 -51.5 20.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 122.327 3.064 . . . . 0.0 110.054 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 161' ' ' PHE . 27.4 tp -78.93 -3.14 43.37 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 126.828 2.58 . . . . 0.0 115.401 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 15.4 t -130.99 -36.08 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 119.213 -2.179 . . . . 0.0 114.158 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . 0.282 . . -91.41 -48.47 6.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 120.21 1.368 . . . . 0.0 108.753 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.76 -47.71 86.93 Favored Glycine 0 C--O 1.188 -2.757 0 N-CA-C 106.237 -2.745 . . . . 0.0 106.237 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.72 -54.37 7.98 Favored 'General case' 0 C--O 1.196 -1.72 1 O-C-N 115.533 -4.51 . . . . 0.0 117.79 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -46.32 -50.73 15.91 Favored 'General case' 0 CA--C 1.475 -1.94 0 O-C-N 116.576 -3.827 . . . . 0.0 112.84 164.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.0 m -63.9 -50.45 68.69 Favored 'General case' 0 N--CA 1.406 -2.672 1 O-C-N 115.213 -4.679 . . . . 0.0 110.829 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.3 p -78.33 -33.58 49.13 Favored 'General case' 0 C--O 1.185 -2.307 0 CA-C-O 116.533 -1.698 . . . . 0.0 113.838 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 12.0 m -54.13 -58.76 6.14 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 116.909 -1.519 . . . . 0.0 109.035 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 2.3 m -63.12 -42.82 99.6 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 116.752 2.131 . . . . 0.0 116.752 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -57.49 -38.73 75.06 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 125.393 1.477 . . . . 0.0 112.109 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.32 -44.52 80.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.91 68.13 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.965 1.257 . . . . 0.0 113.661 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -60.6 -58.9 6.51 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.152 162.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -56.95 -45.48 82.79 Favored 'General case' 0 CA--C 1.613 3.376 0 O-C-N 119.088 -2.258 . . . . 0.0 115.317 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.76 -10.96 11.12 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.112 0 CA-C-O 113.15 -3.31 . . . . 0.0 110.146 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.56 -35.63 34.1 Favored 'General case' 0 N--CA 1.408 -2.551 1 O-C-N 129.949 4.531 . . . . 0.0 106.234 161.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . 0.252 6.9 tt -57.58 -50.91 71.57 Favored 'General case' 0 CA--C 1.599 2.853 0 CA-C-N 125.879 3.945 . . . . 0.0 110.433 164.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.98 -29.48 63.28 Favored 'General case' 0 CA--C 1.604 3.033 0 CA-C-N 122.071 2.214 . . . . 0.0 113.051 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 15.5 mmt -74.64 -26.73 60.07 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 36.2 p -103.73 -19.83 14.17 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.272 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -102.18 111.42 64.35 Favored Pre-proline 0 N--CA 1.513 2.721 0 CA-C-N 121.972 2.169 . . . . 0.0 112.679 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.25 -34.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.261 1.653 0 CA-C-O 114.679 -2.301 . . . . 0.0 108.678 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.4 -37.16 86.55 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 120.574 1.534 . . . . 0.0 112.719 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -71.62 -39.17 70.61 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.232 1.378 . . . . 0.0 114.105 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -55.91 -32.94 64.21 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 115.635 -2.126 . . . . 0.0 111.371 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -82.13 -37.05 26.83 Favored 'General case' 0 C--O 1.171 -3.03 0 CA-C-O 113.898 -2.954 . . . . 0.0 108.892 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.92 -50.05 73.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 22.5 mt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.228 1.58 . . . . 0.0 112.254 171.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 tp -56.44 -42.07 77.51 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.918 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.302 3.9 t70 -65.02 -37.91 89.19 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 131.138 3.775 . . . . 0.0 114.052 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -142.5 75.06 19.41 Favored Pre-proline 0 N--CA 1.498 1.954 0 CA-C-O 126.587 3.089 . . . . 0.0 109.866 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.68 -14.83 28.28 Favored 'Trans proline' 0 C--O 1.177 -2.548 0 O-C-N 117.165 -2.071 . . . . 0.0 115.874 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.281 1.8 pm0 -72.99 -17.83 61.42 Favored 'General case' 0 CA--C 1.599 2.854 0 O-C-N 117.048 -3.532 . . . . 0.0 113.226 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.85 -24.24 31.0 Favored 'General case' 0 C--O 1.266 1.971 0 CA-C-O 114.244 -2.789 . . . . 0.0 109.001 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 72.2 mt -43.86 -45.74 18.87 Favored Pre-proline 0 C--O 1.191 -2.006 0 CA-C-N 121.278 1.853 . . . . 0.0 114.113 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.51 -30.73 28.6 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 124.459 2.628 . . . . 0.0 111.851 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 51.3 m -69.72 -39.47 76.82 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.786 -1.196 . . . . 0.0 109.131 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.37 83.84 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.11 -51.34 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.06 0 CA-C-O 117.178 -1.391 . . . . 0.0 108.44 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -56.06 -48.77 75.43 Favored 'General case' 0 C--O 1.262 1.752 0 C-N-CA 128.84 2.856 . . . . 0.0 110.264 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . 0.251 47.1 tp10 -65.17 -43.47 91.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 118.92 -2.363 . . . . 0.0 113.955 172.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.95 -26.38 64.36 Favored 'General case' 0 N--CA 1.488 1.453 1 O-C-N 115.445 -4.535 . . . . 0.0 110.959 166.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 23.6 m -76.74 -41.81 43.52 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.524 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -69.05 -10.86 59.68 Favored 'General case' 0 C--O 1.167 -3.25 0 C-N-CA 128.749 2.82 . . . . 0.0 106.355 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -102.17 -31.28 10.66 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 116.752 -3.718 . . . . 0.0 110.715 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 18.8 t -29.14 100.26 0.12 Allowed Pre-proline 0 N--CA 1.518 2.951 0 C-N-CA 125.704 1.601 . . . . 0.0 115.232 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.84 7.21 2.08 Favored 'Trans proline' 0 C--O 1.204 -1.189 1 C-N-CA 125.645 4.23 . . . . 0.0 114.162 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 14.1 tp 53.38 46.62 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 128.721 2.808 . . . . 0.0 113.945 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.07 -79.32 0.01 OUTLIER Glycine 1 CA--C 1.448 -4.151 0 C-N-CA 125.629 1.585 . . . . 0.0 115.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 74' ' ' THR . 21.9 m -86.66 -20.73 7.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 O-C-N 117.312 -3.463 . . . . 0.0 112.057 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -6.77 23.65 Favored Glycine 0 N--CA 1.489 2.214 0 CA-C-N 122.795 2.543 . . . . 0.0 115.565 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 310' ' ' SER . 8.9 t -143.94 151.86 40.33 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.898 2.349 . . . . 0.0 108.69 -170.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.38 145.53 43.71 Favored 'General case' 0 CA--C 1.572 1.802 0 O-C-N 128.781 3.8 . . . . 0.0 109.359 161.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.7 164.77 1.06 Allowed Pre-proline 0 CA--C 1.571 1.784 0 C-N-CA 124.398 1.079 . . . . 0.0 112.393 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -80.28 136.81 11.57 Favored 'Trans proline' 0 C--O 1.204 -1.198 0 N-CA-C 107.926 -1.605 . . . . 0.0 107.926 -158.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -108.04 152.69 24.15 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 130.705 3.602 . . . . 0.0 105.551 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -115.94 133.08 56.4 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 119.521 -1.987 . . . . 0.0 109.372 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -74.25 120.65 20.12 Favored 'General case' 0 N--CA 1.412 -2.349 0 O-C-N 118.428 -2.67 . . . . 0.0 105.155 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -84.68 0.53 5.19 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 O-C-N 119.513 -1.992 . . . . 0.0 116.194 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.66 167.12 31.23 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.66 143.85 47.98 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.05 121.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 CA-C-O 123.395 1.569 . . . . 0.0 110.171 -167.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 71.6 p -86.4 143.94 27.56 Favored 'General case' 0 C--O 1.255 1.35 0 O-C-N 116.898 -3.626 . . . . 0.0 111.981 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 61.7 tp -150.11 130.39 13.7 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-O 114.868 -2.491 . . . . 0.0 105.284 -170.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 297' ' ' ARG . 71.4 mtt-85 39.46 44.8 1.19 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 66.47 14.4 62.2 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 119.961 2.745 . . . . 0.0 119.961 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.51 138.84 53.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 90.0 m -77.81 130.07 36.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 127.057 2.143 . . . . 0.0 110.785 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 17.7 mt -91.7 136.33 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 127.911 2.484 . . . . 0.0 105.465 161.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -100.56 151.14 21.94 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 126.863 2.065 . . . . 0.0 108.27 -168.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -52.87 118.62 3.82 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.47 39.07 26.95 Favored Glycine 0 C--N 1.391 3.609 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -126.0 137.34 29.94 Favored Pre-proline 0 C--N 1.368 1.379 0 CA-C-O 117.246 -1.359 . . . . 0.0 107.384 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.89 138.96 8.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 124.535 1.808 . . . . 0.0 115.231 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.3 m -123.0 128.24 75.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 126.474 3.035 . . . . 0.0 107.736 167.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 34.9 mt -88.52 145.85 25.5 Favored 'General case' 0 C--O 1.269 2.131 0 CA-C-N 108.735 -3.848 . . . . 0.0 108.342 163.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -117.85 116.67 27.45 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 119.643 -1.91 . . . . 0.0 109.401 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 284' ' ' THR . 33.3 m -77.24 49.38 0.69 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.1 p -51.13 -41.78 60.28 Favored 'General case' 0 C--O 1.189 -2.08 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -166.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.51 85.65 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 125.064 2.48 . . . . 0.0 116.152 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.55 58.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 117.362 -3.434 . . . . 0.0 113.08 171.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.83 -17.9 54.92 Favored 'General case' 0 N--CA 1.42 -1.972 0 O-C-N 126.545 2.403 . . . . 0.0 108.684 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . 0.275 61.6 t30 -70.78 -1.52 11.81 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 119.352 -2.092 . . . . 0.0 110.558 166.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -136.53 16.47 3.14 Favored 'General case' 0 C--N 1.396 2.589 0 O-C-N 117.566 -3.209 . . . . 0.0 111.149 -168.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -68.04 118.57 11.38 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -59.38 -29.72 67.9 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.881 -1.762 . . . . 0.0 111.899 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -86.34 -7.41 58.49 Favored 'General case' 0 CA--C 1.586 2.33 0 O-C-N 125.115 1.509 . . . . 0.0 114.209 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -96.5 -46.49 6.33 Favored 'General case' 0 N--CA 1.493 1.687 1 CA-C-O 110.389 -4.624 . . . . 0.0 110.71 154.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -120.8 155.65 57.09 Favored Pre-proline 0 C--N 1.393 2.484 1 CA-C-N 129.036 5.38 . . . . 0.0 111.208 -170.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -78.9 130.07 9.34 Favored 'Trans proline' 0 CA--C 1.584 3.009 0 N-CA-C 104.807 -2.805 . . . . 0.0 104.807 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.03 52.38 13.18 Favored 'General case' 0 CA--C 1.575 1.921 0 CA-C-O 124.999 2.333 . . . . 0.0 112.628 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.18 -26.29 52.75 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-O 125.673 2.654 . . . . 0.0 110.974 -147.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.77 -23.63 67.3 Favored 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 128.515 2.726 . . . . 0.0 115.343 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -101.93 169.38 8.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.785 2.834 . . . . 0.0 111.016 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.7 pt -95.63 151.23 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 O-C-N 125.138 1.524 . . . . 0.0 113.215 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -137.82 87.61 2.26 Favored 'General case' 0 CA--C 1.627 3.932 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.158 162.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.92 -6.89 0.99 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.247 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.87 -7.3 53.08 Favored 'General case' 0 N--CA 1.501 2.093 1 O-C-N 115.841 -4.287 . . . . 0.0 112.641 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -73.65 114.51 11.99 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.913 2.085 . . . . 0.0 113.638 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.8 t -166.93 135.84 2.25 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.439 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.17 165.3 32.25 Favored 'Cis proline' 0 C--N 1.301 -1.957 0 O-C-N 123.713 1.375 . . . . 0.0 110.152 -2.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -131.13 157.75 42.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 126.108 1.763 . . . . 0.0 113.898 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.36 157.46 37.15 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 127.24 2.216 . . . . 0.0 109.029 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -153.68 162.56 41.14 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 114.359 -2.734 . . . . 0.0 113.874 -155.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LEU . . . . . . . . . . . . . 46.0 tp -135.22 -2.32 2.53 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -71.56 28.93 0.6 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 126.771 2.129 . . . . 0.0 115.067 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -145.28 11.68 1.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 118.543 1.172 . . . . 0.0 111.293 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 96.69 -177.95 33.42 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 119.021 -1.561 . . . . 0.0 114.104 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -157.97 145.69 18.48 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 118.371 -2.84 . . . . 0.0 112.321 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 59.3 -115.41 7.35 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 117.521 -1.711 . . . . 0.0 110.507 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 35.6 m -94.77 23.23 0.7 Allowed 'Isoleucine or valine' 1 N--CA 1.554 4.728 0 CA-C-N 122.989 3.394 . . . . 0.0 115.916 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -129.31 50.97 2.1 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.94 1.4 . . . . 0.0 112.747 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' HIS . . . . . . . . . . . . 0.283 40.1 p-80 -121.88 153.07 38.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.603 1.561 . . . . 0.0 113.707 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' CYS . . . . . . . . . . . . 0.25 6.8 t -48.45 148.74 1.85 Allowed 'General case' 0 CA--C 1.569 1.692 1 O-C-N 130.668 4.98 . . . . 0.0 113.405 162.086 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 19.9 tp -83.21 -33.31 26.16 Favored 'General case' 0 C--O 1.3 3.718 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' C2C' ' A' ' 401' ' ' HEM . . . -65.97 -23.04 70.92 Favored Glycine 0 CA--C 1.548 2.155 0 C-N-CA 130.047 3.689 . . . . 0.0 121.575 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.54 47.52 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -160.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.37 -32.53 96.75 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 115.904 -2.264 . . . . 0.0 114.043 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.67 -48.86 62.88 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 117.857 -3.027 . . . . 0.0 112.323 169.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.846 -170.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ARG . . . . . . . . . . . . 0.269 12.6 ttt180 -55.51 -40.56 71.94 Favored 'General case' 0 N--CA 1.388 -3.556 0 O-C-N 117.293 -3.379 . . . . 0.0 113.704 160.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 -39.29 27.92 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 114.75 -2.548 . . . . 0.0 109.377 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.47 -62.35 1.78 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 128.014 3.769 . . . . 0.0 115.622 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 71.6 mt -48.33 -32.43 7.41 Favored 'General case' 0 C--O 1.176 -2.791 1 O-C-N 112.474 -6.391 . . . . 0.0 114.73 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -82.56 -49.62 9.68 Favored 'General case' 0 CA--C 1.603 2.989 0 C-N-CA 116.17 -2.212 . . . . 0.0 111.036 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.9 -42.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 O-C-N 124.591 1.182 . . . . 0.0 110.402 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.03 -21.44 64.11 Favored 'General case' 0 CA--C 1.612 3.356 0 O-C-N 118.588 -2.57 . . . . 0.0 115.599 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 16.4 mt -92.09 -34.06 14.53 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 127.813 2.445 . . . . 0.0 110.245 166.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.04 -67.95 0.36 Allowed 'General case' 0 N--CA 1.391 -3.416 0 CA-C-O 126.295 2.95 . . . . 0.0 112.391 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.2 t -81.42 -15.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 CA-C-N 111.187 -2.733 . . . . 0.0 107.981 -161.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.83 -50.27 72.96 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-N 121.477 1.944 . . . . 0.0 110.806 168.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.12 -10.19 59.76 Favored 'General case' 0 C--N 1.375 1.688 0 O-C-N 119.738 -1.851 . . . . 0.0 114.012 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -75.76 -42.11 51.25 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-O 117.037 -1.459 . . . . 0.0 112.457 163.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -105.54 -25.98 12.08 Favored 'General case' 0 CA--C 1.582 2.176 0 CA-C-O 115.895 -2.002 . . . . 0.0 114.778 -161.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 397' ' ' TRP . 34.2 tp -160.36 47.25 0.23 Allowed Pre-proline 0 CA--C 1.572 1.795 0 O-C-N 125.234 1.584 . . . . 0.0 109.82 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -46.15 -18.41 0.42 Allowed 'Trans proline' 0 N--CA 1.482 0.801 0 CA-C-O 111.618 -3.576 . . . . 0.0 113.798 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.84 -16.87 48.5 Favored Glycine 0 CA--C 1.564 3.131 1 CA-C-N 127.683 4.765 . . . . 0.0 113.4 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 17.6 tt -55.29 144.34 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.618 3.563 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -161.79 169.96 20.43 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 130.237 3.415 . . . . 0.0 107.562 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 14.5 tp -74.44 122.84 23.64 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.388 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -84.89 15.94 40.01 Favored Glycine 0 C--O 1.189 -2.684 0 CA-C-O 116.094 -2.503 . . . . 0.0 114.194 -167.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 17.3 pt -144.65 169.24 10.4 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.508 -2.663 . . . . 0.0 112.556 -167.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 375' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -63.06 142.68 88.46 Favored 'Trans proline' 0 N--CA 1.416 -3.088 0 CA-C-N 121.775 1.67 . . . . 0.0 108.051 159.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -70.79 -13.8 62.18 Favored 'General case' 0 C--N 1.388 2.268 0 C-N-CA 115.748 -2.381 . . . . 0.0 112.652 -148.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 41.7 p -90.63 -15.45 30.45 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 119.488 -2.007 . . . . 0.0 107.926 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . 0.276 28.4 mt-30 -89.78 64.39 6.43 Favored 'General case' 0 C--O 1.273 2.332 1 O-C-N 115.553 -4.467 . . . . 0.0 113.611 -156.223 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.13 173.13 6.47 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 124.013 1.864 . . . . 0.0 112.947 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ARG . . . . . 0.532 HH22 ' CD ' ' A' ' 173' ' ' GLU . 34.4 ttp85 -108.48 136.78 47.53 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.994 -1.066 . . . . 0.0 109.717 167.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -105.17 154.46 20.16 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -165.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' SER . . . . . . . . . . . . 0.323 59.1 m -85.31 104.75 15.42 Favored 'General case' 1 N--CA 1.548 4.466 0 C-N-CA 127.425 2.29 . . . . 0.0 114.062 172.665 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.92 33.62 2.53 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -75.52 0.55 60.29 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 119.212 -2.18 . . . . 0.0 117.575 -173.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' MET . . . . . . . . . . . . 0.359 8.1 tpt 69.74 31.15 3.63 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-O 116.067 -1.921 . . . . 0.0 113.168 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.52 -35.45 0.9 Allowed 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 121.445 1.93 . . . . 0.0 114.411 145.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 11.4 mt -119.65 149.79 41.39 Favored 'General case' 0 CA--C 1.462 -2.435 0 C-N-CA 125.601 1.56 . . . . 0.0 113.882 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -117.68 146.02 44.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 124.068 3.122 . . . . 0.0 114.313 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 173.74 169.27 35.84 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.158 -1.589 . . . . 0.0 110.867 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.96 155.1 69.92 Favored 'Trans proline' 0 N--CA 1.521 3.1 0 C-N-CA 125.164 3.909 . . . . 0.0 110.394 169.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.01 -41.84 7.79 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 125.293 2.473 . . . . 0.0 112.695 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -123.39 147.0 47.54 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.985 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' LEU . . . . . . . . . . . . . 5.3 tp -142.76 86.96 9.25 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 125.051 1.34 . . . . 0.0 111.355 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.9 137.9 50.84 Favored 'Trans proline' 0 C--N 1.363 1.338 0 N-CA-C 116.913 1.851 . . . . 0.0 116.913 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' PRO . 4.8 m -141.59 150.61 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 125.866 1.979 . . . . 0.0 114.542 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.14 157.04 43.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 O-C-N 127.747 3.154 . . . . 0.0 110.592 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' TRP . . . . . 0.436 ' CD2' HD21 ' A' ' 367' ' ' LEU . 32.8 p90 . . . . . 0 CA--C 1.493 -1.249 1 O-C-N 115.229 -4.669 . . . . 0.0 110.763 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 401' ' ' HEM . . . . . 0.515 ' C2C' ' HA3' ' A' ' 348' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' MIV . . . . . 0.467 ' H11' ' C5 ' ' A' ' 402' ' ' MIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 . . . . . 0 N--CA 1.5 2.071 0 CA-C-O 115.085 -2.388 . . . . 0.0 111.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -65.47 166.65 18.94 Favored 'Trans proline' 0 C--O 1.264 1.816 0 CA-C-N 125.179 2.885 . . . . 0.0 111.736 -174.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -110.71 149.73 30.06 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.06 115.62 20.6 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 127.719 2.408 . . . . 0.0 109.625 -178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.579 ' CG ' ' HA ' ' A' ' 10' ' ' PRO . 10.3 t80 -101.94 150.49 37.45 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 127.205 2.202 . . . . 0.0 108.103 175.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.579 ' HA ' ' CG ' ' A' ' 9' ' ' TYR . 30.0 Cg_exo -72.69 160.21 95.42 Favored 'Cis proline' 0 C--N 1.399 3.228 0 CA-C-O 125.783 2.326 . . . . 0.0 114.327 -1.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.3 m-30 -95.85 -33.43 12.23 Favored 'General case' 1 C--O 1.309 4.232 0 O-C-N 118.428 -2.67 . . . . 0.0 110.029 174.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 -65.36 171.55 3.83 Favored 'General case' 0 N--CA 1.512 2.672 1 O-C-N 116.248 -4.032 . . . . 0.0 111.336 151.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -157.99 144.77 17.8 Favored 'General case' 1 C--O 1.312 4.346 0 O-C-N 119.774 -1.829 . . . . 0.0 111.284 -176.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.8 m -50.18 -33.89 10.31 Favored 'Isoleucine or valine' 0 C--N 1.377 1.779 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -176.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -87.6 73.86 9.34 Favored 'General case' 0 CA--C 1.5 -0.95 0 O-C-N 117.66 -3.15 . . . . 0.0 114.163 164.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -168.27 177.22 42.47 Favored Glycine 0 N--CA 1.487 2.083 1 CA-C-O 113.299 -4.056 . . . . 0.0 114.692 167.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.311 13.1 mt -128.6 -37.73 1.76 Allowed 'General case' 0 C--O 1.241 0.616 0 N-CA-C 119.2 3.037 . . . . 0.0 119.2 175.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.9 p -92.65 -178.75 4.96 Favored 'General case' 0 C--O 1.268 2.029 0 C-N-CA 114.992 -2.683 . . . . 0.0 109.093 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 tp -63.68 121.3 13.62 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 118.359 -2.713 . . . . 0.0 109.184 169.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . 0.277 . . -58.8 131.52 51.19 Favored 'General case' 0 N--CA 1.519 3.017 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -173.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -55.94 -31.63 58.66 Favored Glycine 0 CA--C 1.558 2.749 0 O-C-N 119.317 -2.115 . . . . 0.0 115.985 -175.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -72.53 -20.59 61.32 Favored 'General case' 0 C--O 1.262 1.762 0 CA-C-O 116.158 -1.877 . . . . 0.0 110.478 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.98 -53.43 7.84 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -69.92 -12.2 67.65 Favored Glycine 0 CA--C 1.564 3.132 0 O-C-N 118.991 -2.318 . . . . 0.0 113.519 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -92.34 -26.35 18.12 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 120.251 -1.735 . . . . 0.0 110.067 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.3 mt -82.79 -30.05 29.14 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-N 120.899 1.682 . . . . 0.0 110.722 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -53.96 -24.22 15.8 Favored 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 116.311 -1.804 . . . . 0.0 115.247 160.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -98.02 -35.11 10.54 Favored 'General case' 0 C--N 1.393 2.49 0 N-CA-C 116.391 1.997 . . . . 0.0 116.391 171.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.9 p -104.97 -7.57 19.18 Favored 'General case' 0 N--CA 1.509 2.52 0 N-CA-C 118.984 2.957 . . . . 0.0 118.984 -174.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -148.2 75.88 10.46 Favored Pre-proline 0 CA--C 1.504 -0.816 0 CA-C-O 128.428 3.966 . . . . 0.0 116.515 158.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -70.37 -12.37 31.63 Favored 'Trans proline' 0 C--O 1.189 -1.962 0 O-C-N 113.813 -3.835 . . . . 0.0 115.632 -158.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.6 p -133.95 118.11 27.99 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.277 0 N-CA-C 116.608 2.077 . . . . 0.0 116.608 154.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 m -100.4 158.42 15.91 Favored 'General case' 0 N--CA 1.529 3.519 0 CA-C-O 113.774 -3.012 . . . . 0.0 117.593 -175.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.1 mmm180 -88.08 136.44 32.97 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 127.284 2.865 . . . . 0.0 106.042 156.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.8 m -129.61 147.18 33.3 Favored 'Isoleucine or valine' 0 C--O 1.254 1.313 0 O-C-N 128.042 3.339 . . . . 0.0 110.166 -177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.9 mtt180 -111.28 112.79 54.58 Favored Pre-proline 0 C--O 1.267 1.982 0 C-N-CA 129.271 3.028 . . . . 0.0 106.442 155.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -73.68 -171.78 0.93 Allowed 'Trans proline' 0 N--CA 1.418 -2.926 0 CA-C-O 128.649 3.521 . . . . 0.0 109.12 159.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_exo -87.52 -23.16 1.44 Allowed 'Trans proline' 1 CA--C 1.625 5.026 0 O-C-N 114.254 -3.603 . . . . 0.0 109.985 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -127.1 133.66 50.38 Favored 'General case' 0 CA--C 1.484 -1.563 0 O-C-N 117.393 -3.317 . . . . 0.0 114.767 172.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.89 176.53 22.28 Favored Glycine 0 N--CA 1.493 2.488 1 O-C-N 114.382 -5.199 . . . . 0.0 112.415 178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -72.65 176.32 5.62 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 127.421 3.486 . . . . 0.0 111.928 176.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.02 152.9 36.82 Favored 'General case' 0 N--CA 1.426 -1.667 0 O-C-N 118.039 -2.913 . . . . 0.0 109.871 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -143.27 165.57 27.11 Favored 'General case' 0 C--O 1.178 -2.699 0 CA-C-O 124.838 2.256 . . . . 0.0 114.284 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -84.18 149.89 25.86 Favored 'General case' 0 CA--C 1.558 1.271 0 O-C-N 120.528 -1.357 . . . . 0.0 108.627 162.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 tp -129.13 112.21 13.74 Favored 'General case' 0 CA--C 1.493 -1.239 0 O-C-N 121.248 -0.907 . . . . 0.0 111.983 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 86.0 t -100.08 132.13 46.23 Favored 'Isoleucine or valine' 0 CA--C 1.578 2.049 0 C-N-CA 128.282 2.633 . . . . 0.0 110.622 -172.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.5 p -121.17 -27.39 4.91 Favored 'General case' 0 CA--C 1.561 1.367 1 C-N-CA 132.324 4.249 . . . . 0.0 116.851 -160.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.5 mmm-85 -100.29 147.41 25.8 Favored 'General case' 0 CA--C 1.57 1.745 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.4 -167.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -49.1 -62.64 1.43 Allowed 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 124.291 1.996 . . . . 0.0 108.165 -169.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . 0.275 70.0 mm-40 -76.01 -9.81 58.92 Favored 'General case' 0 C--O 1.192 -1.966 0 CA-C-O 123.771 1.748 . . . . 0.0 114.269 -170.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -83.58 -32.77 25.6 Favored 'General case' 0 C--N 1.31 -1.123 0 O-C-N 117.719 -3.113 . . . . 0.0 109.838 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.42 -36.12 9.31 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.989 0 O-C-N 118.359 -2.713 . . . . 0.0 109.648 -177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -57.59 -29.42 64.46 Favored 'General case' 0 N--CA 1.507 2.396 0 CA-C-O 116.644 -1.646 . . . . 0.0 112.548 162.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 -50.29 22.47 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 118.786 2.884 . . . . 0.0 118.786 168.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.9 m -80.08 -25.05 11.74 Favored 'Isoleucine or valine' 0 CA--C 1.608 3.186 0 CA-C-N 119.835 1.198 . . . . 0.0 110.232 -177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.3 mt -98.39 35.42 1.79 Allowed 'General case' 0 C--N 1.351 0.659 0 CA-C-O 124.55 2.119 . . . . 0.0 110.023 173.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -156.92 23.69 0.47 Allowed Glycine 0 C--N 1.292 -1.891 0 O-C-N 117.478 -3.264 . . . . 0.0 119.071 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -138.44 135.77 35.55 Favored 'General case' 0 C--O 1.27 2.184 0 CA-C-N 120.174 1.987 . . . . 0.0 108.456 168.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.96 -14.63 53.55 Favored Glycine 0 C--O 1.188 -2.779 0 CA-C-O 116.528 -2.262 . . . . 0.0 114.702 -165.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -84.53 -3.52 58.46 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.54 ' CE2' ' HB2' ' A' ' 290' ' ' ALA . 46.4 m-85 -99.44 121.71 41.51 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 119.575 1.08 . . . . 0.0 111.994 160.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 m -143.94 167.15 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 124.755 1.222 . . . . 0.0 113.475 -175.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -80.04 -21.38 43.54 Favored 'General case' 0 N--CA 1.427 -1.595 0 CA-C-O 115.538 -2.172 . . . . 0.0 113.407 173.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -57.53 -45.21 93.36 Favored Glycine 0 N--CA 1.493 2.471 0 CA-C-N 122.529 2.422 . . . . 0.0 117.148 -150.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -47.59 -27.65 8.0 Favored 'Trans proline' 0 CA--C 1.568 2.212 0 C-N-CA 124.037 3.158 . . . . 0.0 115.868 169.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 99.0 p -50.46 -20.4 1.12 Allowed 'General case' 0 C--O 1.298 3.628 0 CA-C-N 124.04 3.109 . . . . 0.0 113.469 175.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -10.22 59.25 Favored 'General case' 0 CA--C 1.57 1.714 0 O-C-N 119.908 -1.745 . . . . 0.0 112.871 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.5 p -138.96 18.56 2.64 Favored 'General case' 0 N--CA 1.518 2.958 0 CA-C-O 121.827 0.823 . . . . 0.0 110.116 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . 0.251 22.1 mtp180 -135.92 151.92 50.46 Favored 'General case' 0 CA--C 1.572 1.798 0 O-C-N 118.726 -2.484 . . . . 0.0 108.784 167.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -72.08 106.4 4.31 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.743 172.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -88.05 138.67 30.79 Favored Pre-proline 0 CA--C 1.491 -1.303 0 N-CA-C 116.974 2.213 . . . . 0.0 116.974 -158.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -64.87 104.13 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-O 116.917 -1.368 . . . . 0.0 114.829 -172.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -145.79 168.71 20.1 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 125.958 1.703 . . . . 0.0 112.412 -169.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.533 HG21 HG11 ' A' ' 282' ' ' VAL . 27.5 p -88.67 -8.37 54.7 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 119.919 3.303 . . . . 0.0 119.919 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 57.8 mtp85 -126.34 156.49 72.52 Favored Pre-proline 0 N--CA 1.485 1.277 0 O-C-N 117.217 -3.427 . . . . 0.0 116.394 176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.74 -49.35 4.27 Favored 'Trans proline' 1 N--CA 1.397 -4.159 1 C-N-CA 127.88 5.72 . . . . 0.0 111.404 -166.318 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.7 pm0 -72.71 152.77 41.49 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 119.285 3.068 . . . . 0.0 119.285 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.5 mtt -76.88 155.58 32.77 Favored 'General case' 0 CA--C 1.56 1.353 0 O-C-N 119.879 -1.763 . . . . 0.0 108.897 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.2 t -67.09 94.41 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-O 124.827 2.251 . . . . 0.0 108.737 166.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.312 43.4 mmtt -105.94 -19.62 13.68 Favored 'General case' 0 C--N 1.289 -2.027 0 O-C-N 117.482 -3.261 . . . . 0.0 116.755 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -134.76 143.32 14.95 Favored Glycine 0 N--CA 1.506 3.326 0 CA-C-N 125.291 3.678 . . . . 0.0 116.344 -171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.61 159.97 22.11 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 127.327 3.737 . . . . 0.0 109.979 -172.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 9.3 mp -42.38 -28.43 0.21 Allowed 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 119.872 3.286 . . . . 0.0 119.872 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.9 tp -78.04 -0.69 28.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.49 -1.381 . . . . 0.0 113.53 173.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 88.4 p -88.92 19.59 4.03 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-O 123.596 1.665 . . . . 0.0 114.04 163.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' MET . . . . . . . . . . . . . 49.5 mtt -149.34 159.3 44.4 Favored 'General case' 0 N--CA 1.525 3.315 0 O-C-N 117.304 -3.372 . . . . 0.0 111.358 -158.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -142.91 151.12 55.52 Favored Pre-proline 0 C--N 1.363 1.184 0 O-C-N 117.71 -3.119 . . . . 0.0 112.729 -172.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -64.31 144.98 87.72 Favored 'Trans proline' 0 C--O 1.274 2.313 0 C-N-CA 124.626 3.551 . . . . 0.0 116.337 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.15 -14.16 25.92 Favored 'Cis proline' 1 N--CA 1.547 4.625 0 O-C-N 125.271 2.195 . . . . 0.0 115.223 5.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.81 -26.32 68.29 Favored 'General case' 0 C--O 1.223 -0.321 0 O-C-N 118.889 -2.382 . . . . 0.0 116.632 -174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -77.25 -37.71 52.57 Favored 'General case' 0 C--O 1.262 1.745 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 169.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.2 m -62.27 -46.68 87.71 Favored 'General case' 0 C--O 1.278 2.589 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 178.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . 0.412 0.1 OUTLIER -58.5 -33.13 69.46 Favored 'General case' 0 N--CA 1.534 3.755 0 O-C-N 119.871 -1.768 . . . . 0.0 109.567 -179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -51.0 10.13 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 117.013 -1.875 . . . . 0.0 113.771 177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -60.15 -45.98 91.22 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 114.401 -2.714 . . . . 0.0 115.877 175.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 82.6 mtm-85 -46.46 -36.25 6.42 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 125.349 3.704 . . . . 0.0 116.32 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 219' ' ' LEU 0.348 1.3 tt -74.26 -60.1 2.42 Favored 'General case' 0 CA--C 1.616 3.487 0 CA-C-N 113.086 -1.87 . . . . 0.0 110.755 175.099 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . 0.27 22.9 m -65.33 -28.98 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 CA-C-O 114.077 -2.868 . . . . 0.0 109.045 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.0 m -68.39 -20.98 25.95 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 CA-C-N 121.42 1.918 . . . . 0.0 115.737 175.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -76.75 -22.54 53.65 Favored 'General case' 0 N--CA 1.527 3.383 0 CA-C-O 115.643 -2.123 . . . . 0.0 111.593 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -118.3 -34.9 3.94 Favored 'General case' 0 C--O 1.272 2.239 0 CA-C-N 120.245 1.384 . . . . 0.0 111.368 -170.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -73.74 48.03 0.27 Allowed 'General case' 0 CA--C 1.564 1.491 0 O-C-N 118.461 -2.649 . . . . 0.0 110.49 168.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 39.9 p -69.69 157.18 37.76 Favored 'General case' 0 CA--C 1.569 1.7 1 N-CA-C 123.472 4.619 . . . . 0.0 123.472 -172.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.68 -29.34 61.19 Favored 'General case' 0 N--CA 1.476 0.847 0 O-C-N 126.61 2.444 . . . . 0.0 113.401 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . 0.322 16.7 ttt-85 -61.38 -51.26 69.51 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 167.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.3 ttm-85 -55.52 -36.5 66.8 Favored 'General case' 0 N--CA 1.435 -1.22 0 C-N-CA 124.831 1.252 . . . . 0.0 112.989 170.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . 0.357 . . -59.18 -54.34 48.01 Favored 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 171.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.25 4.5 tp10 -49.06 -46.59 44.66 Favored 'General case' 0 CA--C 1.6 2.886 0 CA-C-O 121.821 0.82 . . . . 0.0 112.802 171.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.5 m -76.75 5.5 7.58 Favored 'General case' 0 C--O 1.278 2.604 0 O-C-N 121.372 -0.83 . . . . 0.0 112.865 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 39.6 tp -98.48 -26.58 14.4 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 124.086 0.954 . . . . 0.0 113.09 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -48.94 -42.0 57.14 Favored Pre-proline 1 CA--C 1.665 5.397 0 CA-C-O 112.937 -3.411 . . . . 0.0 111.427 -174.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -58.56 -49.91 10.75 Favored 'Trans proline' 1 CA--C 1.604 4.002 0 O-C-N 124.814 1.955 . . . . 0.0 109.532 -178.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -68.78 -33.38 73.79 Favored 'General case' 0 N--CA 1.528 3.44 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 173.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.41 -33.08 72.46 Favored 'General case' 0 C--O 1.176 -2.804 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.585 176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 29.7 mtt180 -73.86 -36.69 64.87 Favored 'General case' 0 CA--C 1.563 1.453 0 O-C-N 117.673 -3.142 . . . . 0.0 107.814 175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -73.36 -25.12 60.46 Favored 'General case' 0 C--O 1.254 1.319 0 O-C-N 125.636 1.835 . . . . 0.0 113.519 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . 0.276 24.0 mt -66.51 -63.48 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.185 -2.322 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 160.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -48.88 -44.51 39.99 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 -171.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -66.56 -33.73 76.33 Favored 'General case' 0 C--O 1.254 1.314 0 O-C-N 118.136 -2.852 . . . . 0.0 111.7 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -72.74 -41.98 64.58 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 117.15 -3.469 . . . . 0.0 108.794 175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -61.5 -36.15 79.68 Favored 'General case' 0 C--O 1.26 1.612 0 O-C-N 116.665 -3.772 . . . . 0.0 108.431 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . . . . . . . . . 86.9 t -79.93 -30.74 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.85 0 O-C-N 117.964 -2.96 . . . . 0.0 113.969 174.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -61.76 -48.54 80.23 Favored 'General case' 0 CA--C 1.615 3.456 0 C-N-CA 126.029 1.732 . . . . 0.0 109.304 168.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -70.75 -31.69 68.59 Favored 'General case' 0 N--CA 1.537 3.885 0 O-C-N 118.373 -2.704 . . . . 0.0 110.457 176.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 34.9 ttp -61.19 -53.66 54.15 Favored 'General case' 0 C--O 1.259 1.604 0 O-C-N 116.391 -3.943 . . . . 0.0 110.617 170.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -54.77 -49.16 71.56 Favored 'General case' 0 C--O 1.256 1.442 0 CA-C-N 113.545 -1.662 . . . . 0.0 111.104 -175.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . 0.343 . . -64.65 -18.94 65.41 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 129.526 3.131 . . . . 0.0 117.975 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 28.3 m -84.46 -21.92 30.5 Favored 'General case' 0 N--CA 1.506 2.362 0 CA-C-O 114.828 -2.51 . . . . 0.0 111.026 172.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 77.53 179.55 49.56 Favored Glycine 1 N--CA 1.544 5.853 0 CA-C-N 122.576 2.444 . . . . 0.0 112.155 -173.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.28 157.59 53.06 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 127.379 2.458 . . . . 0.0 114.08 -169.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 395' ' ' VAL . 30.0 Cg_endo -67.27 159.1 81.9 Favored 'Cis proline' 0 C--O 1.287 2.963 0 O-C-N 123.719 1.378 . . . . 0.0 110.23 -7.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -120.77 161.22 21.83 Favored 'General case' 0 CA--C 1.586 2.335 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.091 169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 68.2 t0 -93.11 114.3 26.79 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.399 1.0 . . . . 0.0 112.402 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . 0.284 11.8 tp -72.73 -14.36 61.54 Favored 'General case' 0 N--CA 1.515 2.819 0 CA-C-N 114.218 -1.356 . . . . 0.0 113.835 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.9 t -81.65 -44.73 20.39 Favored 'Isoleucine or valine' 0 C--O 1.248 1.006 1 O-C-N 115.373 -4.579 . . . . 0.0 110.239 170.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -74.9 -33.29 62.02 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 117.494 -1.682 . . . . 0.0 107.457 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.0 mtt -100.66 -6.54 25.01 Favored 'General case' 0 C--O 1.201 -1.476 0 O-C-N 119.07 -2.269 . . . . 0.0 110.904 -171.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -135.08 -69.3 0.51 Allowed 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 117.2 2.296 . . . . 0.0 117.2 168.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -59.22 -29.0 67.2 Favored 'General case' 0 CA--C 1.594 2.638 1 O-C-N 115.834 -4.291 . . . . 0.0 114.407 -170.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -77.48 -18.06 57.46 Favored 'General case' 1 N--CA 1.556 4.837 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 172.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . 0.258 50.1 mm-40 -114.13 -15.4 12.24 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 114.536 -2.649 . . . . 0.0 113.905 -164.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 143' ' ' PRO . 22.7 tp -80.48 -50.91 1.06 Allowed Pre-proline 0 N--CA 1.43 -1.444 0 CA-C-O 111.746 -3.978 . . . . 0.0 108.716 176.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.485 ' HD3' ' HB3' ' A' ' 142' ' ' LEU . 71.7 Cg_exo -57.9 -52.75 5.37 Favored 'Trans proline' 0 N--CA 1.518 2.931 0 CA-C-N 125.137 2.87 . . . . 0.0 110.892 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.1 p -66.4 -33.08 61.12 Favored 'Isoleucine or valine' 0 C--O 1.27 2.164 0 CA-C-O 114.649 -2.595 . . . . 0.0 107.515 -160.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . 0.291 64.6 mtt180 -71.91 -49.64 36.0 Favored 'General case' 0 N--CA 1.442 -0.853 0 O-C-N 126.804 2.565 . . . . 0.0 114.768 175.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 18.5 m -55.72 -48.49 77.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 120.856 1.662 . . . . 0.0 109.63 171.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 61.5 mt -67.69 -32.54 57.21 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.342 0 C-N-CA 128.294 2.638 . . . . 0.0 107.751 -171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' CYS . . . . . . . . . . . . . 85.7 m -78.1 -23.05 48.07 Favored 'General case' 0 C--O 1.187 -2.214 0 N-CA-C 118.622 2.823 . . . . 0.0 118.622 170.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -67.95 -53.57 25.26 Favored 'General case' 0 CA--C 1.568 1.662 0 CA-C-N 110.347 -3.115 . . . . 0.0 110.391 167.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 10.5 tp -48.72 -26.03 2.11 Favored 'General case' 0 N--CA 1.414 -2.233 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 170.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 30.9 mt -96.96 -6.03 36.5 Favored 'General case' 0 CA--C 1.592 2.559 0 O-C-N 121.064 -1.023 . . . . 0.0 113.57 176.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 72.34 32.85 62.06 Favored Glycine 0 C--O 1.272 2.488 0 C-N-CA 127.835 2.636 . . . . 0.0 111.065 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 43.7 t -82.78 136.52 44.66 Favored Pre-proline 0 C--O 1.2 -1.525 0 CA-C-O 117.144 -1.408 . . . . 0.0 110.859 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . 0.392 27.4 Cg_exo -51.41 139.09 46.47 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 C-N-CA 122.568 2.179 . . . . 0.0 116.693 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 84.7 p -57.11 -36.65 70.89 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -176.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.54 65.04 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -97.59 -6.13 34.05 Favored 'General case' 0 CA--C 1.57 1.722 0 O-C-N 120.022 -1.673 . . . . 0.0 114.524 169.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -60.92 -26.75 67.7 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 116.516 -2.074 . . . . 0.0 112.566 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -57.33 -53.29 59.85 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 117.947 -2.971 . . . . 0.0 111.822 171.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -56.24 -55.39 33.89 Favored 'General case' 0 C--N 1.385 2.109 0 C-N-CA 121.228 -0.189 . . . . 0.0 110.527 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.473 ' CD1' HD21 ' A' ' 232' ' ' LEU . 18.1 m-85 -53.36 -34.15 56.46 Favored 'General case' 0 N--CA 1.511 2.623 0 N-CA-C 118.807 2.891 . . . . 0.0 118.807 -177.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 91.4 m -56.84 -57.22 13.43 Favored 'General case' 0 N--CA 1.519 2.975 0 CA-C-O 122.219 1.009 . . . . 0.0 108.541 176.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 43.5 ttm105 -63.8 -28.38 69.82 Favored 'General case' 0 C--N 1.393 2.482 0 C-N-CA 128.591 2.756 . . . . 0.0 114.572 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TRP . . . . . . . . . . . . 0.301 46.3 m0 -76.02 -63.88 1.22 Allowed 'General case' 0 N--CA 1.433 -1.325 0 O-C-N 118.555 -2.591 . . . . 0.0 114.325 177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 10.7 m -57.28 -38.45 73.93 Favored 'General case' 0 C--N 1.366 1.309 0 CA-C-N 113.943 -1.48 . . . . 0.0 110.917 172.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -57.03 -31.4 61.53 Favored Glycine 0 C--N 1.346 1.101 0 C-N-CA 129.521 3.438 . . . . 0.0 113.706 173.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.25 38.38 Favored 'General case' 0 C--N 1.282 -2.348 1 O-C-N 115.191 -4.711 . . . . 0.0 110.994 175.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -84.28 -14.6 49.35 Favored 'General case' 0 CA--C 1.603 3.015 0 CA-C-N 122.415 2.371 . . . . 0.0 115.159 162.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.7 mp -79.21 143.13 35.65 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 119.898 -1.751 . . . . 0.0 110.637 -176.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' SER . . . . . . . . . . . . . 71.9 m -79.34 -27.76 42.05 Favored 'General case' 0 N--CA 1.415 -2.197 0 CA-C-N 113.187 -1.824 . . . . 0.0 109.239 166.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -79.68 5.91 12.1 Favored 'General case' 0 C--O 1.264 1.832 0 CA-C-N 121.981 2.173 . . . . 0.0 114.71 177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -140.24 163.69 32.09 Favored 'General case' 0 CA--C 1.496 -1.111 0 O-C-N 117.598 -3.189 . . . . 0.0 113.878 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' CD ' HH22 ' A' ' 380' ' ' ARG . 40.5 mt-10 -126.84 83.98 2.22 Favored 'General case' 0 CA--C 1.609 3.222 0 CA-C-O 125.389 2.519 . . . . 0.0 109.875 -171.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.493 ' CG1' ' HG2' ' A' ' 178' ' ' GLU . 20.3 t -124.08 158.75 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.498 0 O-C-N 117.592 -3.192 . . . . 0.0 111.768 173.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 27.8 p -97.77 175.64 6.1 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 125.701 2.667 . . . . 0.0 108.825 -165.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -69.63 -23.65 63.53 Favored 'General case' 0 C--N 1.372 1.562 0 O-C-N 119.75 -1.844 . . . . 0.0 109.45 -177.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -61.06 -22.95 65.07 Favored 'General case' 0 CA--C 1.461 -2.451 0 O-C-N 116.994 -3.566 . . . . 0.0 111.875 170.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.493 ' HG2' ' CG1' ' A' ' 174' ' ' VAL . 9.2 mp0 -85.97 -31.3 22.15 Favored 'General case' 0 CA--C 1.463 -2.382 0 CA-C-O 114.02 -2.895 . . . . 0.0 110.852 169.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 61.1 mtm -60.43 -36.31 77.89 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-N 125.985 3.993 . . . . 0.0 110.736 170.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -63.49 -39.76 95.3 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 129.505 3.122 . . . . 0.0 109.49 172.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -65.61 -48.53 71.94 Favored 'General case' 0 C--N 1.38 1.913 0 O-C-N 118.344 -2.723 . . . . 0.0 113.763 166.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.21 86.88 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -176.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.05 -27.52 60.96 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -81.03 -46.85 14.4 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 127.275 2.23 . . . . 0.0 114.197 175.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -108.93 -15.45 14.37 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 118.861 2.912 . . . . 0.0 118.861 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . 0.259 . . -92.75 -35.13 13.61 Favored 'General case' 0 CA--C 1.486 -1.515 1 O-C-N 115.048 -4.783 . . . . 0.0 111.034 -166.301 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.11 -30.1 62.16 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.001 -1.851 . . . . 0.0 106.001 177.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -73.92 -38.55 64.28 Favored 'General case' 0 N--CA 1.421 -1.894 0 O-C-N 124.445 1.09 . . . . 0.0 112.75 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -65.64 -33.8 76.73 Favored 'General case' 0 CA--C 1.564 1.494 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 172.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' MET . . . . . . . . . . . . . 12.0 tpp -75.62 -31.75 60.0 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 117.075 -1.85 . . . . 0.0 113.102 174.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -61.37 -49.42 77.65 Favored Glycine 0 CA--C 1.472 -2.628 0 N-CA-C 118.497 2.159 . . . . 0.0 118.497 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -44.88 -41.48 7.17 Favored 'General case' 0 CA--C 1.619 3.615 0 O-C-N 119.053 -2.439 . . . . 0.0 110.538 161.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.443 HD12 ' HA ' ' A' ' 193' ' ' LEU . 19.5 tp -84.25 -37.17 22.09 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 117.763 -3.086 . . . . 0.0 113.705 -178.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 57.1 mt -57.14 -46.68 84.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 125.048 1.339 . . . . 0.0 108.476 170.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -57.13 -42.93 81.85 Favored 'General case' 0 CA--C 1.585 2.314 0 CA-C-N 120.741 1.61 . . . . 0.0 109.494 177.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 41.8 ttt180 -51.41 -44.8 62.36 Favored 'General case' 0 C--N 1.395 2.553 0 CA-C-O 125.761 2.696 . . . . 0.0 112.887 172.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . . . . . . . . . 3.3 mmt180 -71.62 -27.63 63.23 Favored 'General case' 0 N--CA 1.52 3.031 0 O-C-N 118.809 -2.432 . . . . 0.0 112.083 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.9 mtm105 -72.36 -49.99 30.0 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 122.573 1.178 . . . . 0.0 109.354 174.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LYS . . . . . . . . . . . . . 31.1 ttmt -48.55 -53.21 19.11 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.27 -2.241 . . . . 0.0 111.906 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -146.45 115.01 4.5 Favored Pre-proline 0 CA--C 1.595 2.69 0 N-CA-C 106.122 -1.807 . . . . 0.0 106.122 -171.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -75.38 144.72 29.37 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 O-C-N 117.113 -2.098 . . . . 0.0 113.179 172.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 2.6 p -146.48 179.48 7.51 Favored 'General case' 0 C--O 1.219 -0.548 0 C-N-CA 127.871 2.468 . . . . 0.0 107.574 -170.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -86.36 -4.11 59.11 Favored 'General case' 0 C--N 1.377 1.793 0 O-C-N 117.302 -3.374 . . . . 0.0 112.45 -162.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -63.07 166.53 5.8 Favored 'General case' 0 CA--C 1.563 1.468 0 O-C-N 119.293 -2.129 . . . . 0.0 114.788 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 60.7 tp -67.67 -43.95 79.0 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 118.685 0.675 . . . . 0.0 112.436 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.412 HG13 HD22 ' A' ' 224' ' ' LEU . 2.5 t -56.69 -36.01 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.2 m -62.37 -46.25 89.48 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 126.855 2.062 . . . . 0.0 115.727 175.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -61.52 -29.81 70.23 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 125.1 1.5 . . . . 0.0 109.927 172.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 29.4 mt -85.72 -30.54 23.04 Favored 'General case' 0 C--N 1.366 1.317 0 CA-C-O 115.49 -2.195 . . . . 0.0 112.157 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . 0.458 4.9 m -69.42 -12.03 15.55 Favored 'Isoleucine or valine' 0 C--N 1.36 1.062 0 N-CA-C 119.849 3.277 . . . . 0.0 119.849 158.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -106.78 -36.44 6.68 Favored 'General case' 0 CA--C 1.569 1.685 0 CA-C-N 119.538 1.063 . . . . 0.0 109.934 -177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -73.2 149.89 42.53 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 -177.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ARG . . . . . . . . . . . . . 40.7 mmt-85 -134.79 154.22 51.7 Favored 'General case' 0 C--O 1.247 0.969 1 CA-C-O 110.409 -4.615 . . . . 0.0 111.234 174.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -93.09 107.07 18.94 Favored 'General case' 0 C--N 1.248 -3.82 1 O-C-N 129.978 4.549 . . . . 0.0 110.019 162.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 60.74 -92.25 0.03 OUTLIER 'General case' 0 C--O 1.168 -3.222 0 O-C-N 126.891 2.62 . . . . 0.0 109.752 -164.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -129.26 5.71 5.29 Favored 'General case' 0 C--O 1.177 -2.742 0 CA-C-N 120.45 1.477 . . . . 0.0 109.937 170.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -68.38 140.95 55.86 Favored 'General case' 0 N--CA 1.515 2.824 0 CA-C-N 121.041 1.746 . . . . 0.0 114.868 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 1.6 m -113.72 131.37 56.2 Favored 'General case' 0 N--CA 1.407 -2.579 0 CA-C-O 123.927 1.823 . . . . 0.0 111.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LEU . . . . . 0.511 ' HB2' HD13 ' A' ' 97' ' ' LEU . 13.3 tp -70.46 106.1 3.3 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.866 -2.425 . . . . 0.0 110.646 170.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 37.0 m -73.4 169.34 17.36 Favored 'General case' 0 N--CA 1.509 2.505 0 O-C-N 117.375 -3.328 . . . . 0.0 113.704 -174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -50.19 -43.31 52.41 Favored 'General case' 0 C--O 1.19 -2.065 0 O-C-N 126.032 2.082 . . . . 0.0 114.917 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -68.2 -39.07 82.54 Favored 'General case' 0 C--O 1.272 2.277 0 CA-C-N 113.588 -1.642 . . . . 0.0 110.636 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.78 -29.7 69.72 Favored 'General case' 0 C--N 1.378 1.828 0 C-N-CA 126.911 2.084 . . . . 0.0 116.007 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD22 HG13 ' A' ' 206' ' ' VAL . 1.6 tt -93.69 -41.53 9.65 Favored 'General case' 0 N--CA 1.405 -2.684 0 C-N-CA 125.784 1.634 . . . . 0.0 109.88 -176.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 47.6 tp -51.93 -51.95 53.47 Favored 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.484 -0.76 . . . . 0.0 112.436 160.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -53.8 -58.6 6.66 Favored 'General case' 0 C--O 1.267 1.976 0 O-C-N 117.929 -2.982 . . . . 0.0 113.705 172.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -49.86 -51.55 39.34 Favored 'General case' 0 CA--C 1.563 1.444 0 CA-C-O 122.072 0.939 . . . . 0.0 111.514 177.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -64.9 -39.41 93.48 Favored 'General case' 0 CA--C 1.587 2.376 0 CA-C-N 111.993 -2.367 . . . . 0.0 115.854 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.406 HD12 ' HA ' ' A' ' 229' ' ' ILE . 4.7 tp -62.46 -49.77 82.54 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.703 0 O-C-N 119.836 -1.79 . . . . 0.0 108.98 172.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . -51.09 -36.37 35.1 Favored Glycine 0 C--N 1.373 2.599 0 CA-C-O 117.62 -1.655 . . . . 0.0 114.568 168.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LEU . . . . . . . . . . . . . 14.2 tp -72.3 -51.5 20.48 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 122.327 3.064 . . . . 0.0 110.054 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.473 HD21 ' CD1' ' A' ' 161' ' ' PHE . 27.4 tp -78.93 -3.14 43.37 Favored 'General case' 0 C--N 1.288 -2.094 0 O-C-N 126.828 2.58 . . . . 0.0 115.401 -176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' VAL . . . . . . . . . . . . . 15.4 t -130.99 -36.08 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.532 0 O-C-N 119.213 -2.179 . . . . 0.0 114.158 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . 0.282 . . -91.41 -48.47 6.87 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 120.21 1.368 . . . . 0.0 108.753 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . -62.76 -47.71 86.93 Favored Glycine 0 C--O 1.188 -2.757 0 N-CA-C 106.237 -2.745 . . . . 0.0 106.237 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -45.72 -54.37 7.98 Favored 'General case' 0 C--O 1.196 -1.72 1 O-C-N 115.533 -4.51 . . . . 0.0 117.79 164.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -46.32 -50.73 15.91 Favored 'General case' 0 CA--C 1.475 -1.94 0 O-C-N 116.576 -3.827 . . . . 0.0 112.84 164.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 8.0 m -63.9 -50.45 68.69 Favored 'General case' 0 N--CA 1.406 -2.672 1 O-C-N 115.213 -4.679 . . . . 0.0 110.829 -173.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.3 p -78.33 -33.58 49.13 Favored 'General case' 0 C--O 1.185 -2.307 0 CA-C-O 116.533 -1.698 . . . . 0.0 113.838 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' THR . . . . . . . . . . . . . 12.0 m -54.13 -58.76 6.14 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 116.909 -1.519 . . . . 0.0 109.035 166.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' THR . . . . . . . . . . . . . 2.3 m -63.12 -42.82 99.6 Favored 'General case' 0 C--O 1.197 -1.695 0 N-CA-C 116.752 2.131 . . . . 0.0 116.752 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLN . . . . . . . . . . . . . 5.4 tp60 -57.49 -38.73 75.06 Favored 'General case' 0 C--N 1.372 1.552 0 C-N-CA 125.393 1.477 . . . . 0.0 112.109 171.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 79.3 mt -69.32 -44.52 80.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.75 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -71.24 -31.91 68.13 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 119.965 1.257 . . . . 0.0 113.661 -171.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -60.6 -58.9 6.51 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.804 -1.089 . . . . 0.0 111.152 162.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -56.95 -45.48 82.79 Favored 'General case' 0 CA--C 1.613 3.376 0 O-C-N 119.088 -2.258 . . . . 0.0 115.317 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -86.76 -10.96 11.12 Favored 'Isoleucine or valine' 0 C--O 1.189 -2.112 0 CA-C-O 113.15 -3.31 . . . . 0.0 110.146 -174.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -80.56 -35.63 34.1 Favored 'General case' 0 N--CA 1.408 -2.551 1 O-C-N 129.949 4.531 . . . . 0.0 106.234 161.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LEU . . . . . . . . . . . . 0.252 6.9 tt -57.58 -50.91 71.57 Favored 'General case' 0 CA--C 1.599 2.853 0 CA-C-N 125.879 3.945 . . . . 0.0 110.433 164.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 18.4 tp -56.98 -29.48 63.28 Favored 'General case' 0 CA--C 1.604 3.033 0 CA-C-N 122.071 2.214 . . . . 0.0 113.051 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 15.5 mmt -74.64 -26.73 60.07 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 115.078 1.511 . . . . 0.0 115.078 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . . . . . . . . . 36.2 p -103.73 -19.83 14.17 Favored 'General case' 0 CA--C 1.575 1.916 0 CA-C-N 112.96 -1.927 . . . . 0.0 114.272 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -102.18 111.42 64.35 Favored Pre-proline 0 N--CA 1.513 2.721 0 CA-C-N 121.972 2.169 . . . . 0.0 112.679 173.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -91.25 -34.84 0.06 OUTLIER 'Trans proline' 0 C--O 1.261 1.653 0 CA-C-O 114.679 -2.301 . . . . 0.0 108.678 -170.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -64.4 -37.16 86.55 Favored 'General case' 0 C--N 1.36 1.041 0 CA-C-N 120.574 1.534 . . . . 0.0 112.719 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 53.2 tp -71.62 -39.17 70.61 Favored 'General case' 0 C--N 1.369 1.438 0 CA-C-N 120.232 1.378 . . . . 0.0 114.105 170.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ARG . . . . . . . . . . . . . 31.3 ttp-105 -55.91 -32.94 64.21 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 115.635 -2.126 . . . . 0.0 111.371 173.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -82.13 -37.05 26.83 Favored 'General case' 0 C--O 1.171 -3.03 0 CA-C-O 113.898 -2.954 . . . . 0.0 108.892 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -56.92 -50.05 73.76 Favored 'General case' 0 C--N 1.37 1.465 0 N-CA-C 118.501 2.778 . . . . 0.0 118.501 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 22.5 mt -67.61 -38.49 84.01 Favored 'General case' 0 N--CA 1.508 2.45 0 O-C-N 125.228 1.58 . . . . 0.0 112.254 171.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 18.5 tp -56.44 -42.07 77.51 Favored 'General case' 0 C--N 1.367 1.369 0 C-N-CA 117.963 -1.495 . . . . 0.0 111.918 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . 0.302 3.9 t70 -65.02 -37.91 89.19 Favored 'General case' 0 CA--C 1.564 1.518 0 C-N-CA 131.138 3.775 . . . . 0.0 114.052 173.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -142.5 75.06 19.41 Favored Pre-proline 0 N--CA 1.498 1.954 0 CA-C-O 126.587 3.089 . . . . 0.0 109.866 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.68 -14.83 28.28 Favored 'Trans proline' 0 C--O 1.177 -2.548 0 O-C-N 117.165 -2.071 . . . . 0.0 115.874 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLU . . . . . . . . . . . . 0.281 1.8 pm0 -72.99 -17.83 61.42 Favored 'General case' 0 CA--C 1.599 2.854 0 O-C-N 117.048 -3.532 . . . . 0.0 113.226 176.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 46.9 tp -83.85 -24.24 31.0 Favored 'General case' 0 C--O 1.266 1.971 0 CA-C-O 114.244 -2.789 . . . . 0.0 109.001 177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 72.2 mt -43.86 -45.74 18.87 Favored Pre-proline 0 C--O 1.191 -2.006 0 CA-C-N 121.278 1.853 . . . . 0.0 114.113 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -68.51 -30.73 28.6 Favored 'Trans proline' 0 C--N 1.357 0.975 0 CA-C-N 124.459 2.628 . . . . 0.0 111.851 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' SER . . . . . . . . . . . . . 51.3 m -69.72 -39.47 76.82 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 120.786 -1.196 . . . . 0.0 109.131 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ALA . . . . . . . . . . . . . . . -67.61 -38.37 83.84 Favored 'General case' 0 C--O 1.2 -1.508 0 N-CA-C 115.756 1.762 . . . . 0.0 115.756 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 72.4 t -60.11 -51.34 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.605 3.06 0 CA-C-O 117.178 -1.391 . . . . 0.0 108.44 173.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -56.06 -48.77 75.43 Favored 'General case' 0 C--O 1.262 1.752 0 C-N-CA 128.84 2.856 . . . . 0.0 110.264 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . 0.251 47.1 tp10 -65.17 -43.47 91.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 118.92 -2.363 . . . . 0.0 113.955 172.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 59.3 mt -58.95 -26.38 64.36 Favored 'General case' 0 N--CA 1.488 1.453 1 O-C-N 115.445 -4.535 . . . . 0.0 110.959 166.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' THR . . . . . . . . . . . . . 23.6 m -76.74 -41.81 43.52 Favored 'General case' 0 C--O 1.194 -1.85 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.524 177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ARG . . . . . . . . . . . . . 2.4 tmm_? -69.05 -10.86 59.68 Favored 'General case' 0 C--O 1.167 -3.25 0 C-N-CA 128.749 2.82 . . . . 0.0 106.355 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' TRP . . . . . . . . . . . . . 22.1 t90 -102.17 -31.28 10.66 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 116.752 -3.718 . . . . 0.0 110.715 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 18.8 t -29.14 100.26 0.12 Allowed Pre-proline 0 N--CA 1.518 2.951 0 C-N-CA 125.704 1.601 . . . . 0.0 115.232 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -72.84 7.21 2.08 Favored 'Trans proline' 0 C--O 1.204 -1.189 1 C-N-CA 125.645 4.23 . . . . 0.0 114.162 176.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 14.1 tp 53.38 46.62 25.92 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 128.721 2.808 . . . . 0.0 113.945 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 56.07 -79.32 0.01 OUTLIER Glycine 1 CA--C 1.448 -4.151 0 C-N-CA 125.629 1.585 . . . . 0.0 115.821 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.533 HG11 HG21 ' A' ' 74' ' ' THR . 21.9 m -86.66 -20.73 7.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 O-C-N 117.312 -3.463 . . . . 0.0 112.057 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 113.99 -6.77 23.65 Favored Glycine 0 N--CA 1.489 2.214 0 CA-C-N 122.795 2.543 . . . . 0.0 115.565 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 310' ' ' SER . 8.9 t -143.94 151.86 40.33 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-N 120.898 2.349 . . . . 0.0 108.69 -170.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ALA . . . . . . . . . . . . . . . -74.38 145.53 43.71 Favored 'General case' 0 CA--C 1.572 1.802 0 O-C-N 128.781 3.8 . . . . 0.0 109.359 161.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 32.8 m-85 -54.7 164.77 1.06 Allowed Pre-proline 0 CA--C 1.571 1.784 0 C-N-CA 124.398 1.079 . . . . 0.0 112.393 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -80.28 136.81 11.57 Favored 'Trans proline' 0 C--O 1.204 -1.198 0 N-CA-C 107.926 -1.605 . . . . 0.0 107.926 -158.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -108.04 152.69 24.15 Favored 'General case' 0 N--CA 1.52 3.029 0 C-N-CA 130.705 3.602 . . . . 0.0 105.551 170.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -115.94 133.08 56.4 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 119.521 -1.987 . . . . 0.0 109.372 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . 0.54 ' HB2' ' CE2' ' A' ' 61' ' ' PHE . . . -74.25 120.65 20.12 Favored 'General case' 0 N--CA 1.412 -2.349 0 O-C-N 118.428 -2.67 . . . . 0.0 105.155 170.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . 0.301 6.8 m -84.68 0.53 5.19 Favored 'Isoleucine or valine' 0 C--O 1.265 1.919 0 O-C-N 119.513 -1.992 . . . . 0.0 116.194 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -154.66 167.12 31.23 Favored 'General case' 0 CA--C 1.582 2.201 0 N-CA-C 103.844 -2.65 . . . . 0.0 103.844 171.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -72.66 143.85 47.98 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 117.627 2.454 . . . . 0.0 117.627 -175.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.05 121.14 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.523 3.202 0 CA-C-O 123.395 1.569 . . . . 0.0 110.171 -167.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' THR . . . . . . . . . . . . . 71.6 p -86.4 143.94 27.56 Favored 'General case' 0 C--O 1.255 1.35 0 O-C-N 116.898 -3.626 . . . . 0.0 111.981 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 61.7 tp -150.11 130.39 13.7 Favored 'General case' 0 N--CA 1.385 -3.706 0 CA-C-O 114.868 -2.491 . . . . 0.0 105.284 -170.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 297' ' ' ARG . 71.4 mtt-85 39.46 44.8 1.19 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 66.47 14.4 62.2 Favored Glycine 0 N--CA 1.501 2.997 0 N-CA-C 119.961 2.745 . . . . 0.0 119.961 179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' VAL . . . . . . . . . . . . . 30.4 m -127.51 138.84 53.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.104 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' THR . . . . . . . . . . . . . 90.0 m -77.81 130.07 36.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 127.057 2.143 . . . . 0.0 110.785 -178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 17.7 mt -91.7 136.33 24.71 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 C-N-CA 127.911 2.484 . . . . 0.0 105.465 161.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 -100.56 151.14 21.94 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 126.863 2.065 . . . . 0.0 108.27 -168.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -52.87 118.62 3.82 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 165.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLY . . . . . . . . . . . . . . . 77.47 39.07 26.95 Favored Glycine 0 C--N 1.391 3.609 0 N-CA-C 115.584 0.994 . . . . 0.0 115.584 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -126.0 137.34 29.94 Favored Pre-proline 0 C--N 1.368 1.379 0 CA-C-O 117.246 -1.359 . . . . 0.0 107.384 -172.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -83.89 138.96 8.33 Favored 'Trans proline' 0 N--CA 1.497 1.695 0 O-C-N 124.535 1.808 . . . . 0.0 115.231 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.3 m -123.0 128.24 75.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 CA-C-O 126.474 3.035 . . . . 0.0 107.736 167.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 34.9 mt -88.52 145.85 25.5 Favored 'General case' 0 C--O 1.269 2.131 0 CA-C-N 108.735 -3.848 . . . . 0.0 108.342 163.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' ALA . . . . . . . . . . . . . . . -117.85 116.67 27.45 Favored 'General case' 0 N--CA 1.417 -2.077 0 O-C-N 119.643 -1.91 . . . . 0.0 109.401 176.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 284' ' ' THR . 33.3 m -77.24 49.38 0.69 Allowed 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 114.467 1.284 . . . . 0.0 114.467 -175.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' THR . . . . . . . . . . . . . 1.1 p -51.13 -41.78 60.28 Favored 'General case' 0 C--O 1.189 -2.08 0 N-CA-C 117.347 2.351 . . . . 0.0 117.347 -166.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' GLY . . . . . . . . . . . . . . . -59.48 -35.51 85.65 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 125.064 2.48 . . . . 0.0 116.152 173.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' ALA . . . . . . . . . . . . . . . -75.89 -30.55 58.86 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 117.362 -3.434 . . . . 0.0 113.08 171.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -78.83 -17.9 54.92 Favored 'General case' 0 N--CA 1.42 -1.972 0 O-C-N 126.545 2.403 . . . . 0.0 108.684 -179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASN . . . . . . . . . . . . 0.275 61.6 t30 -70.78 -1.52 11.81 Favored 'General case' 0 CA--C 1.568 1.657 0 O-C-N 119.352 -2.092 . . . . 0.0 110.558 166.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -136.53 16.47 3.14 Favored 'General case' 0 C--N 1.396 2.589 0 O-C-N 117.566 -3.209 . . . . 0.0 111.149 -168.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -68.04 118.57 11.38 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 -177.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLN . . . . . . . . . . . . . 76.1 mm-40 -59.38 -29.72 67.9 Favored 'General case' 0 N--CA 1.484 1.268 0 O-C-N 119.881 -1.762 . . . . 0.0 111.899 175.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -86.34 -7.41 58.49 Favored 'General case' 0 CA--C 1.586 2.33 0 O-C-N 125.115 1.509 . . . . 0.0 114.209 176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -96.5 -46.49 6.33 Favored 'General case' 0 N--CA 1.493 1.687 1 CA-C-O 110.389 -4.624 . . . . 0.0 110.71 154.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -120.8 155.65 57.09 Favored Pre-proline 0 C--N 1.393 2.484 1 CA-C-N 129.036 5.38 . . . . 0.0 111.208 -170.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -78.9 130.07 9.34 Favored 'Trans proline' 0 CA--C 1.584 3.009 0 N-CA-C 104.807 -2.805 . . . . 0.0 104.807 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASP . . . . . . . . . . . . . 25.6 t0 48.03 52.38 13.18 Favored 'General case' 0 CA--C 1.575 1.921 0 CA-C-O 124.999 2.333 . . . . 0.0 112.628 175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -77.18 -26.29 52.75 Favored 'General case' 0 N--CA 1.416 -2.175 0 CA-C-O 125.673 2.654 . . . . 0.0 110.974 -147.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -64.77 -23.63 67.3 Favored 'General case' 0 CA--C 1.578 2.034 0 C-N-CA 128.515 2.726 . . . . 0.0 115.343 169.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 -101.93 169.38 8.81 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 128.785 2.834 . . . . 0.0 111.016 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ILE . . . . . . . . . . . . . 16.7 pt -95.63 151.23 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.679 0 O-C-N 125.138 1.524 . . . . 0.0 113.215 169.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -137.82 87.61 2.26 Favored 'General case' 0 CA--C 1.627 3.932 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.158 162.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 12.2 m -59.92 -6.89 0.99 Allowed 'Isoleucine or valine' 1 N--CA 1.544 4.247 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -171.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -74.87 -7.3 53.08 Favored 'General case' 0 N--CA 1.501 2.093 1 O-C-N 115.841 -4.287 . . . . 0.0 112.641 174.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ARG . . . . . . . . . . . . . 11.3 ttp-105 -73.65 114.51 11.99 Favored 'General case' 0 N--CA 1.506 2.354 0 C-N-CA 126.913 2.085 . . . . 0.0 113.638 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' THR . . . . . . . . . . . . . 14.8 t -166.93 135.84 2.25 Favored Pre-proline 0 N--CA 1.479 1.003 0 CA-C-O 116.374 -1.774 . . . . 0.0 110.439 177.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -61.17 165.3 32.25 Favored 'Cis proline' 0 C--N 1.301 -1.957 0 O-C-N 123.713 1.375 . . . . 0.0 110.152 -2.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -131.13 157.75 42.29 Favored 'General case' 0 C--O 1.206 -1.236 0 C-N-CA 126.108 1.763 . . . . 0.0 113.898 -175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -155.36 157.46 37.15 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 127.24 2.216 . . . . 0.0 109.029 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' HIS . . . . . . . . . . . . . 31.2 p-80 -153.68 162.56 41.14 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 114.359 -2.734 . . . . 0.0 113.874 -155.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LEU . . . . . . . . . . . . . 46.0 tp -135.22 -2.32 2.53 Favored 'General case' 0 N--CA 1.538 3.951 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' GLY . . . . . . . . . . . . . . . -71.56 28.93 0.6 Allowed Glycine 0 C--N 1.338 0.652 0 C-N-CA 126.771 2.129 . . . . 0.0 115.067 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -145.28 11.68 1.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 118.543 1.172 . . . . 0.0 111.293 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' GLY . . . . . . . . . . . . . . . 96.69 -177.95 33.42 Favored Glycine 0 CA--C 1.559 2.816 0 C-N-CA 119.021 -1.561 . . . . 0.0 114.104 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' HIS . . . . . . . . . . . . . 78.2 t60 -157.97 145.69 18.48 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 118.371 -2.84 . . . . 0.0 112.321 -167.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' GLY . . . . . . . . . . . . . . . 59.3 -115.41 7.35 Favored Glycine 0 N--CA 1.493 2.434 0 CA-C-O 117.521 -1.711 . . . . 0.0 110.507 174.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 35.6 m -94.77 23.23 0.7 Allowed 'Isoleucine or valine' 1 N--CA 1.554 4.728 0 CA-C-N 122.989 3.394 . . . . 0.0 115.916 170.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -129.31 50.97 2.1 Favored 'General case' 0 CA--C 1.507 -0.693 0 O-C-N 124.94 1.4 . . . . 0.0 112.747 -169.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' HIS . . . . . . . . . . . . 0.283 40.1 p-80 -121.88 153.07 38.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 125.603 1.561 . . . . 0.0 113.707 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' CYS . . . . . . . . . . . . 0.25 6.8 t -48.45 148.74 1.85 Allowed 'General case' 0 CA--C 1.569 1.692 1 O-C-N 130.668 4.98 . . . . 0.0 113.405 162.086 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' LEU . . . . . . . . . . . . . 19.9 tp -83.21 -33.31 26.16 Favored 'General case' 0 C--O 1.3 3.718 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 172.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.515 ' HA3' ' C2C' ' A' ' 401' ' ' HEM . . . -65.97 -23.04 70.92 Favored Glycine 0 CA--C 1.548 2.155 0 C-N-CA 130.047 3.689 . . . . 0.0 121.575 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.54 47.52 Favored Pre-proline 0 N--CA 1.506 2.336 0 N-CA-C 117.62 2.452 . . . . 0.0 117.62 -160.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.37 -32.53 96.75 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 115.904 -2.264 . . . . 0.0 114.043 174.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 11.0 tp -68.67 -48.86 62.88 Favored 'General case' 0 CA--C 1.484 -1.558 0 O-C-N 117.857 -3.027 . . . . 0.0 112.323 169.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' ALA . . . . . . . . . . . . . . . -72.26 -19.19 61.74 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 117.551 -1.66 . . . . 0.0 113.846 -170.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ARG . . . . . . . . . . . . 0.269 12.6 ttt180 -55.51 -40.56 71.94 Favored 'General case' 0 N--CA 1.388 -3.556 0 O-C-N 117.293 -3.379 . . . . 0.0 113.704 160.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 44.1 t -77.34 -39.29 27.92 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.589 0 CA-C-O 114.75 -2.548 . . . . 0.0 109.377 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -56.47 -62.35 1.78 Allowed 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 128.014 3.769 . . . . 0.0 115.622 172.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LEU . . . . . . . . . . . . . 71.6 mt -48.33 -32.43 7.41 Favored 'General case' 0 C--O 1.176 -2.791 1 O-C-N 112.474 -6.391 . . . . 0.0 114.73 168.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -82.56 -49.62 9.68 Favored 'General case' 0 CA--C 1.603 2.989 0 C-N-CA 116.17 -2.212 . . . . 0.0 111.036 174.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' VAL . . . . . . . . . . . . . 65.6 t -58.9 -42.0 84.59 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.32 0 O-C-N 124.591 1.182 . . . . 0.0 110.402 177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' ALA . . . . . . . . . . . . . . . -69.03 -21.44 64.11 Favored 'General case' 0 CA--C 1.612 3.356 0 O-C-N 118.588 -2.57 . . . . 0.0 115.599 -170.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LEU . . . . . . . . . . . . . 16.4 mt -92.09 -34.06 14.53 Favored 'General case' 0 C--N 1.308 -1.198 0 C-N-CA 127.813 2.445 . . . . 0.0 110.245 166.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -61.04 -67.95 0.36 Allowed 'General case' 0 N--CA 1.391 -3.416 0 CA-C-O 126.295 2.95 . . . . 0.0 112.391 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' VAL . . . . . . . . . . . . . 9.2 t -81.42 -15.11 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 CA-C-N 111.187 -2.733 . . . . 0.0 107.981 -161.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' LEU . . . . . . . . . . . . . 15.2 tp -61.83 -50.27 72.96 Favored 'General case' 0 C--N 1.366 1.32 0 CA-C-N 121.477 1.944 . . . . 0.0 110.806 168.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' LEU . . . . . . . . . . . . . 17.7 mt -79.12 -10.19 59.76 Favored 'General case' 0 C--N 1.375 1.688 0 O-C-N 119.738 -1.851 . . . . 0.0 114.012 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -75.76 -42.11 51.25 Favored 'General case' 0 C--O 1.255 1.356 0 CA-C-O 117.037 -1.459 . . . . 0.0 112.457 163.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -105.54 -25.98 12.08 Favored 'General case' 0 CA--C 1.582 2.176 0 CA-C-O 115.895 -2.002 . . . . 0.0 114.778 -161.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' LEU . . . . . 0.436 HD21 ' CD2' ' A' ' 397' ' ' TRP . 34.2 tp -160.36 47.25 0.23 Allowed Pre-proline 0 CA--C 1.572 1.795 0 O-C-N 125.234 1.584 . . . . 0.0 109.82 177.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -46.15 -18.41 0.42 Allowed 'Trans proline' 0 N--CA 1.482 0.801 0 CA-C-O 111.618 -3.576 . . . . 0.0 113.798 174.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . . . . . . . . . . . -60.84 -16.87 48.5 Favored Glycine 0 CA--C 1.564 3.131 1 CA-C-N 127.683 4.765 . . . . 0.0 113.4 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' ILE . . . . . . . . . . . . . 17.6 tt -55.29 144.34 6.74 Favored 'Isoleucine or valine' 0 CA--C 1.618 3.563 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' ARG . . . . . . . . . . . . . 48.2 ptt85 -161.79 169.96 20.43 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 130.237 3.415 . . . . 0.0 107.562 177.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' LEU . . . . . . . . . . . . . 14.5 tp -74.44 122.84 23.64 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 110.324 -3.126 . . . . 0.0 113.388 -173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLY . . . . . . . . . . . . . . . -84.89 15.94 40.01 Favored Glycine 0 C--O 1.189 -2.684 0 CA-C-O 116.094 -2.503 . . . . 0.0 114.194 -167.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' ILE . . . . . . . . . . . . . 17.3 pt -144.65 169.24 10.4 Favored Pre-proline 0 CA--C 1.582 2.191 0 CA-C-O 114.508 -2.663 . . . . 0.0 112.556 -167.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -63.06 142.68 88.46 Favored 'Trans proline' 0 N--CA 1.416 -3.088 0 CA-C-N 121.775 1.67 . . . . 0.0 108.051 159.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -70.79 -13.8 62.18 Favored 'General case' 0 C--N 1.388 2.268 0 C-N-CA 115.748 -2.381 . . . . 0.0 112.652 -148.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' THR . . . . . . . . . . . . . 41.7 p -90.63 -15.45 30.45 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 119.488 -2.007 . . . . 0.0 107.926 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' GLN . . . . . . . . . . . . 0.276 28.4 mt-30 -89.78 64.39 6.43 Favored 'General case' 0 C--O 1.273 2.332 1 O-C-N 115.553 -4.467 . . . . 0.0 113.611 -156.223 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.13 173.13 6.47 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 124.013 1.864 . . . . 0.0 112.947 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ARG . . . . . 0.532 HH22 ' CD ' ' A' ' 173' ' ' GLU . 34.4 ttp85 -108.48 136.78 47.53 Favored 'General case' 0 CA--C 1.487 -1.48 0 O-C-N 120.994 -1.066 . . . . 0.0 109.717 167.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -105.17 154.46 20.16 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -165.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' SER . . . . . . . . . . . . 0.323 59.1 m -85.31 104.75 15.42 Favored 'General case' 1 N--CA 1.548 4.466 0 C-N-CA 127.425 2.29 . . . . 0.0 114.062 172.665 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -99.92 33.62 2.53 Favored 'General case' 0 C--N 1.275 -2.67 0 N-CA-C 120.766 3.617 . . . . 0.0 120.766 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' GLY . . . . . . . . . . . . . . . -75.52 0.55 60.29 Favored Glycine 1 N--CA 1.519 4.183 0 O-C-N 119.212 -2.18 . . . . 0.0 117.575 -173.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' MET . . . . . . . . . . . . 0.359 8.1 tpt 69.74 31.15 3.63 Favored 'General case' 0 C--O 1.202 -1.395 0 CA-C-O 116.067 -1.921 . . . . 0.0 113.168 172.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.52 -35.45 0.9 Allowed 'General case' 0 N--CA 1.428 -1.556 0 CA-C-N 121.445 1.93 . . . . 0.0 114.411 145.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' LEU . . . . . . . . . . . . . 11.4 mt -119.65 149.79 41.39 Favored 'General case' 0 CA--C 1.462 -2.435 0 C-N-CA 125.601 1.56 . . . . 0.0 113.882 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ARG . . . . . . . . . . . . . 66.6 mtm180 -117.68 146.02 44.01 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 124.068 3.122 . . . . 0.0 114.313 178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 173.74 169.27 35.84 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.158 -1.589 . . . . 0.0 110.867 -178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.96 155.1 69.92 Favored 'Trans proline' 0 N--CA 1.521 3.1 0 C-N-CA 125.164 3.909 . . . . 0.0 110.394 169.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' LEU . . . . . . . . . . . . . 58.9 tp -98.01 -41.84 7.79 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 125.293 2.473 . . . . 0.0 112.695 169.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -123.39 147.0 47.54 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 112.038 -2.346 . . . . 0.0 110.985 169.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' LEU . . . . . . . . . . . . . 5.3 tp -142.76 86.96 9.25 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 125.051 1.34 . . . . 0.0 111.355 -178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -65.9 137.9 50.84 Favored 'Trans proline' 0 C--N 1.363 1.338 0 N-CA-C 116.913 1.851 . . . . 0.0 116.913 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' PRO . 4.8 m -141.59 150.61 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 O-C-N 125.866 1.979 . . . . 0.0 114.542 177.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.14 157.04 43.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.939 0 O-C-N 127.747 3.154 . . . . 0.0 110.592 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' TRP . . . . . 0.436 ' CD2' HD21 ' A' ' 367' ' ' LEU . 32.8 p90 . . . . . 0 CA--C 1.493 -1.249 1 O-C-N 115.229 -4.669 . . . . 0.0 110.763 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' HEM . . . . . 0.515 ' C2C' ' HA3' ' A' ' 348' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' MIV . . . . . 0.467 ' H11' ' C5 ' ' A' ' 402' ' ' MIV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_